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RACE ON END-OF-LIFE TREATMENT LEVEL FOLLOWING A PALLIATIVE
INTERVENTION
by
KATHLEEN BENTON
(Under the Direction of James Stephens)
ABSTRACT
The purpose of this study was to examine differences in treatment level at the end
of life according to race and socioeconomic status and the extent a palliative intervention
may change the course and cost of care. The study population included patients from the
Medical Center of Central Georgia (N=2,920). The data were examined as a secondary
analysis retrospectively. Data from the medical record and a unique clinical database
were coded into descriptive, predictor, and outcome variables to define the population,
and the patient’s treatment status before and after the intervention. McNemar’s test of
symmetry, Chi Square, and Logistic Regression models were used to examine
relationships between predictor and outcome variables including race, gender, age,
disease, income, and education levels affecting code status, comfort status and discharge
to hospice. Costs pre- and post-intervention were also examined using the t-test. Results
demonstrated that the palliative intervention had a significant effect on costs and care
level. Further, African Americans with lower levels of education were more likely to
choose aggressive measures than Caucasians. Findings may improve understanding of the
palliative intervention and encourage culturally competent end-of-life education.

INDEX WORDS: Socioeconomic status, Race, End of life care, Palliative care, Code
status, Comfort measures
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CHAPTER 1
INTRODUCTION
Background
The economics of death, including high healthcare costs at the end of life, are well
documented (Zhang et al., 2009). However, no appropriate value for spending at the end
of life is known. Historical trends for end-of-life spending document the particularly high
costs associated with care in the last year of life (Emanuel & Emanuel, 1994; Luce &
Rubenfield, 2002). According to Reynolds, Cooper, and McKneally (2005), many issues
contribute to this dilemma. Glass and Nahapetyan (2008) believe that it is attributable to
America’s “death denying culture” (p. 4). Others argue that because heightened
technology has become so effective at extending life, it becomes more difficult to
recognize what defines end of life (Reynolds et al., 2005). Though the United States
medical system allows for continued aggressive care for the dying, disparities still exist
in basic primary care; and in comparison with other countries, America still views
mortality as a choice (Lown, 1998).
Fr. Thomas Nairn (2009) wrote that there are few professionals who are willing to
provide comprehensive end-of-life guidance. The Patient Self Determination Act of 1991
increased the autonomy of the patient and proposed the use of advance care planning
documents to motivate end-of-life discussions (Grimaldo, et al., 2001). Yet, many
healthcare providers in America still have not reached the point where they are ready to
lead these difficult discussions, at least not until they become forced to do so (Nairn,
2009).
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In 2010, The New Yorker published a case study that centered on a young female
patient who was diagnosed with lung cancer shortly before she delivered her first child.
Her physician wrote about the final three months of this woman’s life, which included
four rounds of chemotherapy and countless tests and hospital visits. Similar to other case
studies on patients and their end of life (Srivasta, 2007), this woman’s life ended in a
hospital bed against her wishes to die peacefully at home – a consequence of the medical
world’s inability to ease her into the dying process (Gawande, 2010). For a patient with a
fatal disease, the aggressive treatments and utilization of expensive resources at the end
of life may include “three-thousand-dollar-a-day intensive care, five-thousand-dollar-anhour surgery. But, ultimately death comes...” (Gawande, 2010, p. 3).
Palliative care includes interdisciplinary symptom management with the goal of
improved quality of life through the use of clinical, emotional, psychosocial, and spiritual
triggers (Griffin, Koch, Nelson, & Cooley, 2007). A variety of palliative models have
been utilized and published (Babcock & Robinson, 2011; Crawford & Price, 2003; Curtis
& Rubenfield, 2005; Nelson et al., 2010; Spugnardi, 2008). One aspect of the palliative
discipline is the ability of the trained healthcare professional to engage in a meaningful
discussion about patient feelings on quality of life and wishes for the end of life.
Palliative care is not Hospice. Hospice care is defined as end-of-life care exclusively,
with no aggressive measures (National Hospice and Palliative Care Organization
(NHPCO), 2009). Palliative care can include management of symptoms at the same time
that the patient is receiving aggressive treatment for the underlying condition (Griffin et
al., 2007).
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Research documents consistent differences on end-of-life treatment preferences
according to race, and more recently studies have included socioeconomic status as a
predictor for these same decisions (Muni, Engelberg, Treece, Dotolo, & Curtis, 2011).
African American patients are more likely to choose aggressive care at the end of life,
even though their use of medical interventions at disease diagnosis is less common
(Johnson et. al, 2010). Efforts to address potentially inappropriate and burdensome
aggressive care decisions for all populations have been made through the work of the
palliative care and hospice movements (e.g., Center to Advance Palliative Care (CAPC),
2009; NHPCO, 2009).
The literature includes an abundance of studies indicating that the use of a
palliative intervention results in cost savings for the system, as well as quicker deescalation, meaning a shift in care from high level aggressive measures like artificial
supports and therapeutic medications to pain control and withdrawal of support (Appleby,
2006; Emanuel & Emanuel, 1994; Hansen, Usher, Spragens, & Bernard, 2008; Meier &
Beresford, 2008; Zhang et al., 2009). De-escalation may include changes to care such as
Do Not Resuscitate, or DNR orders, withdrawal of care decisions, and hospice
discharges. Through the use of successful palliative care models, effective and
appropriate comfort measures also lead to healthcare resource savings, while providing
enhanced quality and support to patients and their families at a critical time (Meier &
Beresford, 2008).
Purpose of the Study
The purpose of this study was to examine differences in treatment level at the end
of life according to socioeconomic status and race. Data included treatment level
3

measurements before and after the palliative intervention using a secondary data set.
Length of stay costs aligned with treatment level was also examined relative to
socioeconomic status and race.
The Transitions Palliative Care Model is a counseling-initiated palliative model
used at the Medical Center of Central Georgia in Macon, (MCCG). This study used preexisting retrospective quantitative data collected by the program to examine code status,
care level shift to comfort measures only, hospice decisions, and costs associated with
care level and length of stay before and after the palliative intervention.
Significance of the Study
This study adds to the literature in two distinct ways. First, while there is a
growing body of literature on race and ethnic disparities in healthcare, few studies
address racial disparities specific to the end of life (Bach, Cramer, Warren, & Begg,
1999; Barnato et al., 2006; Borum, Lynn, & Zhong, 2000; Degenholtz, Thomas, &
Miller, 2003; Epstein & Ayanian, 2001; Muni et al.,). Second, few studies address
socioeconomic status as a confounder to racial differences in care choice (Muni et al.,
2011; Fiscella & Franks, 2001; Fowler et al., 2010; Franks & Fiscella, 2002; Muni, et al.,
2011). This research addressed both areas of disparity in public health.
Two measures of effective public health practice include improved quality of life
and more efficient allocation of resources (Teitelbaum & Wilensky, 2009). Healthcare
spending constitutes 17% of the Gross Domestic Product, and this is far greater than any
other expenditure in the US, including national defense (Finkler, 2005). President Barack
Obama initially pledged $675 billion towards healthcare reform in 2009. This figure
remains ever-increasing. President Obama has asked hospitals, physicians and
4

administrators to stand by their pledge to be more efficient with healthcare dollars in their
medical practices (Inglehart, 2009). The significance of end-of-life care on healthcare
costs is evident throughout the literature (Appleby, 2006; Emanuel & Emanuel, 1994;
Hansen, et al., 2008; Meier & Beresford, 2008; Zhang et al., 2009).
Healthcare resources spent at the end of life are well documented, with care in the
last week of life accounting for higher costs and poorer quality end-of-life experience
when end-of-life discussions have not taken place (Zhang et.al, 2009). When end-of-life
discussions do not occur, futile aggressive care continues and a prolonged death with
poor quality and high costs may result (Glass & Nahapetyan, 2008). Participant
physicians in one study asserted that this type of conversation is not in their training, and
that the importance of their role is curing and healing, not discussing “unimportant” side
effects (Hordern & Street, 2007). However, beyond the quality of subsequent death is the
concern for what quality of life will accompany the progression of a disease. A Palliative
care team has been proven to be more effective than other professionals in healthcare at
leading discussions about quality of life and end-of-life care options (Fineberg, 2005).
After all information is shared and communication barriers are addressed, patients and
families may continue to choose artificial support. Some patient values may align with
this quality of end of life. However, the success of the intervention is the ability to
inform and educate (Babcock & Robinson, 2010).
Millions of people each year are diagnosed with terminal illness and may benefit
from palliative measures to improve quality of life outcomes. Furthermore, issues of
quality of life during illness are critical to overall public health practice (Adunsky,
Aminoff, Bechor, Arad, & Bercovitch, 2008). Psychological and physiological distress,
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produced by a patient’s inability to cope with the adverse events from disease and
treatment, affects the magnitude of poor quality of life (Lethborg, Aranda, Cox &
Kissane, 2007).
Definition of Terms
The following are terms used throughout this research and are relevant to the
purpose and significance of the study. This section provides definitions to ensure that the
reader is familiar with key terms used in this dissertation paper.
Advance Directive. Advance Directives allow a patient to have their wishes
upheld at end of life when they cannot speak for themselves. They include both the living
will and the durable power of attorney for healthcare (Tierny et al., 2001).
Code Status. For the purpose of this research, Code Status will reference the care
status levels described below including DNR or Do Not Resuscitate, full code, and Status
IV comfort measures.
Consult. A consult is defined for the purpose of this research as a referral made from
one physician service to another program or service. It is a formal request to assess a
patient.
De-escalation of Care. For the purpose of this research, De-escalation of Care is
defined as any downward level treatment changes including Do Not Resuscitate, or DNR
orders, withdrawal of care decisions, and hospice discharges.
DNR. DNR is the acronym for Do Not Resuscitate. This is an order written by a
licensed physician and with consent from a patient or authorized party in reference to
code status. The DNR code status, also Status II-Status IV at MCCG means there will be
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no emergency treatment when a cardiac or respiratory arrest occurs. (Medical Center of
Central Georgia, 2007).
End-of-life Care. End-of-life Care is defined in this paper as care for the terminally ill
patient.
Full Code. Full Code is defined as no DNR order in place and all emergency
treatment given in the event of a cardiac or respiratory arrest. Full code also means full
resuscitation or CPR, cardio-pulmonary resuscitation. Resuscitation is a combination of
medicines and machines utilized to re-start respirations and the heart (Medical Center of
Central Georgia, 2007).
Hospice. Hospice care is defined as end-of-life care exclusively, with no aggressive
measures aimed at curative results (NHPCO, 2009).
Length of Stay. Length of Stay (LOS) is another tool to determine resources saved.
Decreasing LOS may include overall hospital stay or proof of decreasing stay in a
medical intensive care unit (Norton et al., 2007).
MCCG. The Medical Center of Central Georgia, Macon, GA. For the purpose of this
research MCCG will be used to reference the entity where data collection and treatment
was conducted.
Palliative Care. Palliative care includes interdisciplinary symptom management with
the goal of improved quality of life through the use of clinical, emotional, psychosocial,
and spiritual triggers. This care is not mutually exclusive to aggressive measures (Griffin
et al., 2007).
Palliative Care Model. Palliative Care Models are defined as those which include the
interdisciplinary team of physician, nurse, social worker, spiritual counselor, volunteer
7

and pharmacist. This team works together to share “a philosophy of care and an
organized, highly structured system…” (Crawford, 2011, p.13). For this research, a
palliative program is interchangeable with palliative model.
Palliative Care Team. Palliative care is a multidisciplinary approach to the relief of
symptoms and suffering and the improvement of overall quality of life during illness. The
Palliative Care Team is made up of all disciplines involved in this goal. Palliative care
team consultation includes a discussion surrounding long term goals of the patient/family
including advance care planning and/or care at the end of life. The care team is patient
and family centered (Griffin et al., 2007).
Race. Race will include Caucasian (White) and African American (Black) patients
only. For the purpose of this research, race is determined based on scripted questions
asked at registration for MCCG patients in which patients self report their personal racial
association. Race is not under the auspices of ethnicity for this research.
Socioeconomic Status. Income and education will define a patient’s Socioeconomic
Status (SES) based on the census tract that correlates with the patient’s address. For the
purpose of this research, SES is determined by address using a geocoding method
described in the methodology section of this paper.
Status One. For the purpose of this research, Status One is defined by MCCG as
complete care, no restrictions. The patient will receive all necessary medical care
including CPR, full code (Medical Center of Central Georgia, 2007). This is also
referenced as aggressive care throughout this paper.
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Status Two. For the purpose of this research, Status Two will not be included but is
defined by MCCG as complete care, no CPR in cardiac/respiratory arrest (Medical
Center of Central Georgia, 2007).
Status Three. For the purpose of this research, Status Three will not be included but
is defined by MCCG as care and comfort plus other therapies agreed upon by authorized
party and physician (Center for Palliative care, MCCG, Resuscitation Policy, 2007).
Status Four. For the purpose of this research, Status Four is defined by MCCG as no
CPR, care and comfort only. This paper will also define the care as comfort measures
only (Center for Palliative Care MCCG, Resuscitation Policy, 2007).
Literature Review
In 2007, The New England Journal of Medicine published a case study which
explained some of the issues surrounding end-of-life care decisions. The patient was a
young married man with three small children. When his cough started, his doctors did
not think the case was serious, and thus he was prescribed a series of antibiotics
(Srivastava, 2007).
It was not until lab work showed an iron deficiency that the physicians confirmed
a terminal diagnosis and doctors prescribed aggressive care. The patient’s wife focused
on each life-prolonging treatment measure, while the patient slowly realized his own
demise was imminent (Srivastava, 2007).
Each new round of physicians offered options, all of which excluded the reality of
the patient’s impending death. Though the diagnosis was clearly terminal, the patient
was never discharged from the hospital nor offered choices of symptom management or
end-of-life care. Instead, the healthcare specialists kept him in the hospital for additional
9

tests. On the day before he died, an order was written for a liver biopsy. Specialists
planned to investigate his liver failure instead of addressing the end of his life – then
suddenly, it was over. Everyone, including the experts, seemed shocked – they never let
him know; they never let him go (Srivastava, 2007).
This study will investigate the end-of-life choices patients make at MCCG. Unlike
the case presented above, this study’s patients will have had a palliative intervention prior
to death. The purpose of this study is to examine if there are differences in treatment level
at the end of life based on socioeconomic status and race. Data will include treatment
level measurements before and after the palliative intervention. The Transitions model is
a counseling-based palliative model used at MCCG. This study will utilize pre-existing
retrospective quantitative data collected by this program to examine code status,
withdrawal of care, and hospice decisions. Furthermore, the study will look at potential
cost savings and length of stay following a palliative consult.
Palliative Care
There is some misunderstanding and lack of acceptance surrounding the palliative
discipline in healthcare. Because death and end of life may be viewed as a “therapeutic
failure” by physicians, the end-of-life stigma creates a barrier to the success of palliative
programs (Baider & Wein, 2001, p. 98). Palliative care is a multidisciplinary approach to
the relief of symptoms and suffering, and its goal is the improvement of overall quality of
life during illness. Palliative care does not require that death be imminent, and such care
may include aggressive treatment of the underlying diseases as well as pain and symptom
management. Palliative care is patient- and family-centered, and it includes discussions
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surrounding the patient’s long term goals, including advance care planning and/or care at
the end of life (Griffin et al., 2007).
Palliative programs have been developed to meet the pain and symptom
management needs of the populations with disease, and to help families and patients
understand their therapeutic options (Gade et al., 2008). Palliative care as a discipline is
relatively new. A significant SUPPORT study on communication at end of life took place
prior to the palliative movement, and the study’s failure highlights the need for the
palliative discipline (Knaus et al., 1995).
The SUPPORT phase I prospective observational study and phase II randomized
control trial was conducted in the early 1990s with a goal of improving communication in
end-of-life care and reducing deaths on life-sustaining support. Five well-accredited
academic hospitals participated over a two-year time period. Participants included 9,105
adults hospitalized with a life-threatening disease (Knaus et al., 1995). In the phase I
portion of the study, poor communication was observed to highlight the breakdown in
care goals between the physician and patient at the end of life. In the phase II
intervention, communication was enhanced and information was heightened to physicians
and patients through the work of trained SUPPORT nurses. Results from the study
yielded no improvement in communication breakdown or decrease in prolonged deaths
through the use of life-sustaining therapies. The study authors speculated that the failure
of the intervention proved the ongoing need for consistent interventions to discuss
advance care planning and goals of care. Without name, it highlighted the need for
palliative care in hospitals. This study holds historical significance as credible research
evidencing the need for palliative care interventions (Knaus, 1995).
11

There are now numerous studies on the positive effects of palliative care (Edens,
Harvey, & Gilden, 2010; Gade et al., 2008; Temel et al., 2010). A recent randomized
control trial compared patients with non-small-cell lung cancer who received palliative
care with those who did not (Temel et al., 2010). Both groups received state-of-the-art
cancer treatment at a major research center. Participants included 151 randomly assigned
patients who received either standard oncological care or palliative care incorporated
with standard oncological treatment. The palliative patients not only scored higher
quality-of-life ratings, but also lived three months longer than those patients who only
received aggressive measures. Overall, patients who received the early palliative
intervention received less aggressive care measures and still had longer length of life.
The study showed that early palliative care led to an increase in documented resuscitation
preferences, a decrease in chemotherapy, and an increase hospice use. The study’s
significant results showed lower costs yielded a longer life for these patients (Temel et
al., 2010).
Palliative care is essentially quality-of-life care. It is not necessarily exclusive to
end-of-life care, but it does impact and influence the type of care that is received at end of
life. This sub-specialty of medicine embraces all psychological, physiological, and
spiritual symptoms that may contribute to poor quality of life. For example, despite the
variety in diagnoses, fatigue and pain remain some of the most debilitating symptoms of
many illnesses (Kutner, Bryant, Beaty, & Fairclough, 2006). Quality-of-life studies have
shown that these symptoms improve over time with palliation involvement. Because
palliative care includes spiritual discussions and quality-of-life discussions, patients may
12

have the chance to define what constitutes individual quality of life and may be better
able to define how to balance the risks and benefits of proposed interventions (Gade et
al., 2008). Palliative care may improve quality of the dying experience and improve
deaths that lack meaning, dignity, and overall comfort (Dunn, 2005).
Only a small percentage of cancer patients are routinely given information about
life expectancy and alternative palliative treatments during diagnosis and treatment visits
(Kim et al., 2008). If a patient with a terminal illness never receives a palliative consult,
the goals for care may be set only around treatment, with no discussion of the inevitable
finality. Many patients with terminal illness die without ever having a discussion about
end of life (Temel et al., 2010). Palliative medicine is the hope for control of this
problem. Improved communication, especially discussions on advance directives, and
treatment preferences are key to the palliative process. These may lead to improve both
quality and quantity of life (Griffin et al., 2007).
The Center to Advance Palliative Care (CAPC) is a centralized resource for
hospitals and palliative programs that offers guidance and technical assistance. CAPC has
developed best practices and has provided standardization to the discipline (Weissman &
Meier, 2008). In addition to studying the variation and design of different palliative
programs throughout the United States (Spugnardi, 2008), CAPC has also convened a
panel to address barriers inhibiting palliative interventions, such as resource issues and
referrals made late in the progression of illness. As a quality improvement initiative, this
panel developed a set of checklists for hospitals and physicians to use at registration and
at subsequent patient visits (Weissman & Meier, 2011).
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In March 2010, CAPC notified hospitals that the quality accreditation agency
known as The Joint Commission developed a palliative care certification. This highlights
the importance of having a palliative program within hospital settings, as a measure of
healthcare quality (Center for the Advancement of Palliative Care, 2010). Only recently
has the Joint Commission designated palliative care as a “necessary intervention” (Edens
et al., 2010, p. 379).
In 2003, 25% of hospitals had palliative care programs, and programs were found
to be more prevalent in facilities with a higher number of beds (Morrison, Maroney-Galin
Kravolec, & Meier, 2005). In a study examining the variability in prevalence of
programs across the U.S., Georgia was ranked on the lower end of average, with only 2040% of hospitals recorded as having programs, dependent upon the hospital status:
community, public, not-for profit or for-profit status. This is below the current national
average of 52.8% and compares with 100% in Vermont, and 80%-plus in the District of
Columbia, New Hampshire, and Montana. Georgia does surpass states like Mississippi at
10% and Alabama at 16%. Variability was high across U.S. programs dependent upon the
culture of the institution (Goldsmith, Dietrich, Qingling, & Morrison, 2008).
The National Palliative Care Registry created by the Center for the Advancement
of Palliative Care conducted a review of hospital palliative care programs across the
nation, through a self-reporting mechanism, for data obtained from 2008 (2009). 420
hospitals responded and 363 of those reported seeing patients through palliative
consultation services. Recommendations for future palliative work included funding a
dedicated director, establishing a data collection and reporting mechanism consistent with
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infrastructure, ensuring the program is aligned with the institutional mission and ensuring
palliative care was integrated into all relevant service lines (Weisman & Meier, 2008).
Palliative Care Models
Palliative care models include an interdisciplinary team of physician, nurse, social
worker, spiritual counselor, volunteer and pharmacist. This team works together to share
“a philosophy of care and an organized, highly structured system…” (Crawford, 2011,
p.13). Currently, only three states in the U.S are cited as having a grade A rank on their
reported number of palliative care programs (Spugnardi, 2008). These include Vermont,
Montana, and New Hampshire. In a recent review by Babcock and Robinson (2010),
most palliative programs follow a medical model with the advanced care practice nurse
or physician as the key component (Gade et. al., 2008; Nelson et al., 2010; Santa-Emma,
Roach, Gill, Spayde, & Taylor, 2002). An interdisciplinary approach is consistent
throughout all models including, at a minimum, a pain management specialist, a
psychosocial professional, a spiritual leader, and a practitioner. The central component of
each program is improving quality of life (Babcock & Robinson, 2011).
Teamwork in decision making is “…an integral part of palliative care…”
(Crawford & Price, 2003, p. 1). Just as an organization needs a mission and vision, so
too does an effective palliative care team (Crawford & Price, 2003). The team shares the
suffering with the patient, thereby removing some of the burden from the patient and
family (Wakefield, 1999). The role of the palliative worker is to treat dying as a normal
process and to treat a patient as a whole being instead of as an ailing organ. (Rokach,
2005).
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The most common palliative model cited by Meier and Beresford (2007) is
referred to as the consultation model. Similar to other services within the hospital
community, the attending physician consults the palliative program to assess and confer
with their patient. Typically, in other areas of the hospital, consultation is to one
discipline, for example a specialist physician, a physical therapist or a social worker. A
palliative consult is made to multiple disciplines at one time. The referring physician is
the program’s client and continues to guide patient care (Meier & Beresford, 2007).
Communication between the managing physician and the palliative consult service is a
key part of addressing goals of care and symptom management (Meier & Beresford,
2007).
A less common model, the integrative approach, exists when palliative
philosophies are woven throughout a clinical unit, often in an intensive care setting
(Nelson et al., 2010). Though palliative care is often seen as targeting patients with
cancer, all diseases can potentially benefit from the services (Curtis & Rubenfield, 2005).
Physician organizations such as the American College of Chest Physicians support an
interdisciplinary approach in their patients with severe or life-threatening pulmonary or
cardiac diseases, when led by the attending physician (Selecky, Hall, Varkey &
McCaffree, 2005).
Planning for a palliative model includes the involvement of key stakeholdersboth clinicians and non-clinicians- for pre-program planning and education to explain
how a palliative program can enhance a complex healthcare system. The palliative
discipline often utilizes consult triggers, order sets for pain management, and explicit
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policies for de-escalation of care, such as for the withdrawal of mechanical ventilation.
Programs should develop evaluation systems to assess the effectiveness of the program
and document the shift in quality measures post intervention (Radwany, et al., 2009).
The continued goal is the prevention of unnecessary suffering (Priest et al., 2009).
One of the key components of a good model is the ability to motivate and
efficiently see referrals. This means physicians must feel motivated to write for a
palliative consult, and timely coordination of all palliative services must be available. A
successful palliative program must be continuously marketed (Meier, 2005). Meier
(2005) recommended that a program use physicians to champion the outreach to
specialists, engage managing physicians on an individual level, mold to the facility’s
culture, develop an easy consultation process, and maximize the ability to grow in consult
volume. Once the consult has been initiated, one of the most important tools of the
palliative intervention is the family conference. Variations in models include the target
population, for example a pediatric model. Pediatric populations cite an ongoing issue
with quality treatment for children with life-limiting illness, prompting similar
interdisciplinary models, which may even include extended education to families and
disciplines like art therapy (Browning & Solomon, 2005).
Regardless of the model type, programs seek to raise awareness about the
contributions and benefits of their services. Some different geographic model structures
described in a study by Meier and Beresford (2006) include: (1) a closed unit, in which
the management of the patient is transferred to the palliative physician and the patient is
admitted to a palliative bed; (2) an open unit, where the referring physician transfers the
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patient to the palliative unit but continues to serve as the attending physician; (3) a
geographically separate unit in which the patient is isolated to palliative only care, staff
and physicians; (4) an integrated unit where palliative patients occupy some of the beds
and beds are versatile for other medically managed patients; and finally, (5) a hospice
inpatient unit where palliative patients are intermixed with hospice patients admitted to
the same unit. Because palliative care is tied so closely to hospice services, confusion
may result from how the two differ. National experts recommend that hospital palliative
care coordinate well with hospice services so that the palliative team has the ability to
specify which service would be most appropriate for the patient (Meier, 2005).
Palliative Care versus Hospice
Palliative care programs in acute care hospitals may provide a transition into the
hospice setting (Gade et al., 2008). For example, in one study, 72% of patients discharged
from a hospital palliative program entered hospice care (Santa-Emma et al., 2002). There
are several options that a patient may choose when diagnosed with a terminal illness in
the U. S. The primary option is usually curative, aggressive care. Unfortunately for some,
curative care does not always lead to more benefit than harm. In these cases, the hospice
option better addresses the patient and family’s need (Stevenson & Bramson, 2009).
However, admission into hospice is not limited to those whose death is imminent.
Researchers followed 4,493 patients through the progression of their terminal
illness, some with hospice, and others without. The average survival was 29 days longer
for hospice patients than for those who did not choose hospice (Connor, Pyenson, Fitch,
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Spence, & Iwasaki, 2007), suggesting that hospice care may actually improve quality as
well as quantity of life.
Though hospice care correlates with patient and family satisfaction, length of stay
is very low nationally, with referrals frequently made late in the progression of disease.
Hospice care differs from palliative care in its general requirement for a limited
prognosis. To receive hospice, a patient must be certified as in the last six months of life,
whereas palliative patients are designated as life-limiting, terminal or chronic and may
receive care for an undefined amount of time, even years (Crawford, 2011). Hospice care
includes palliative measures 100% of the time, but palliative care does not necessarily
always include hospice. To understand the difference more clearly, it is important to
define the hospice benefit.
Funding is provided by the federal government to support hospice care in
certified agencies using a per diem reimbursement format. When the Medicare hospice
benefit was started by the federal government, a major purpose was to save money.
Terminal patients make up a large percentage of health care costs. Research on end stage
renal disease, for example, showed that these patients exhaust a large amount of
healthcare dollars and resources if treatment continues in the hospital (Ross, Alza, &
Jadeja, 2006). At times this is appropriate, but when treatment is no longer therapeutic,
de-escalation may embrace patient values. Hence, hospice may be a cost effective way to
care for patients who no longer benefit from aggressive hospital care and instead should
be cared for in alternate facilities with less aggressive care.
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Since the advent of the Medicare hospice benefit in 1972, the funding and
reimbursement has increased. However, a relatively low number of studies have been
conducted on the administrative reimbursement and certification surrounding end-of-life
care and hospice (Kirby, Keefe & Nichols, 2007). Prior to the hospice benefit, end of
life was reimbursed per expense and was usually costly. As a result of these fiscal flaws,
the government felt it necessary to come up with some alternative, which resulted in the
hospice benefit to help lessen the direct patient cost (Stevenson & Bramson, 2009). If a
hospice is certified, Medicare then provides a flat, per diem rate. The per diem rate is
used to fund the care including nurse, nurse assistant, equipment, and medications related
to symptom control for the illness (Hamilton, 1994).
In 1982, Congress qualified which specifications must be met in order to be a
Medicare certified hospice (Hamilton, 1994). According to Stevenson and Bramson
(2009), the hospice benefit was originally intended primarily for cancer patients, allowing
quality end-of-life care at home and reducing unnecessary hospitalizations. Eventually,
the benefit expanded to other end-stage patients. When the policy was originally
conceived, it was more specific to a particular type of patient prognosis and included a
cap of 210 days for use. The goal from a Medicare perspective was to replace aggressive
care with a palliative approach for the dying (Banaszak-Holl & Mor, 1996). Savings
would come from providing care in a less expensive setting like a home. However,
because of the expansion of nursing home placement with hospice, the policy benefit was
extended in 1989 to allow nursing homes to contract with hospice agencies and receive
reimbursement.
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To receive the benefit, a physician must certify a patient is six months or less in
life expectancy, based upon natural disease progression. Care is divided into two phases.
The first consists of two 90-day periods in which the patient is allowed 90 days of
hospice care without reassessment. The second phase consists of an unlimited number of
60-day periods. provided the patient continues to meet the prognosis criteria even though
they outlive the initial six months. There is no established cap on duration if criteria for
terminal prognosis are still met. There are four levels of care within the hospice benefit.
These include routine homecare, 24-hour continuing homecare, inpatient hospice care,
and inpatient respite care. The per diem payment for home hospice is between $65 and
$140 per day with a total cap per patient of $22,386.15 (Stevenson & Bramson, 2009).
There are now nearly 5,000 hospice programs throughout the country in all fifty
states and the District of Columbia (National Hospice and Palliative Organization, 2009).
There has been little research reviewing hospice services and quality across facilities
(Stevenson & Bramson, 2009). The American population is an aging population, and
therefore the use of palliative and end-of-life care is increasing. Hospice agencies have
grown considerably from admitting 1,000 patients annually at the onset of the benefit to
700,000 patients annually in 2000 (Kirby et.al, 2007). Nursing home enrollees have
tripled in the last 15 years. Traditional medical care is sometimes viewed as poor for endof-life patients and hospice is a way to improve that care (Stevenson & Bramson, 2009).
Institutions like Skilled Nursing Facilities (SNF) and hospital based hospices have
experienced increasing patient volumes since the expansion of the hospice benefit
(Banaszak & Mor, 1996). These entities work with outside hospice agencies that provide
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in-house care in the nursing home or hospital. Therefore, Medicare is paying twice, first
for the hospice benefit and, second for the care in that institution. This may not achieve
Medicare’s cost effectiveness goal. Although the goal of less medications and less
aggressive care is achieved, an inpatient bed can result in high costs for institutions, and
the baseline reimbursement may not cover these costs. There are arguments for and
against this double payment system. Experts agree that the hospice benefit may need
more well-defined government regulations in order to develop a true standard of care for
hospice within an institution and to achieve the desired cost savings (Grabowski,
Huskamp, Stevensom & Keating, 2007).
The growth of utilization rates in the hospice benefit has led to a major increase in
for-profit hospices, which has drastically shaped the end-of-life standard and
reimbursement environment. Hospice facilities have become more efficient and
competitive. In 2005, the national median length of stay in a hospice was only three
weeks- with one third enrolling for one week prior to death- despite the fact that the
benefit can extend for six months (Kapo et. al, 2005). Late admission into hospice limits
the number of palliative care services a patient receives which could reduce the quality of
the dying experience. It also suggests there is a lack of knowledge and understanding of
how hospice services can be added to the transitional benefit of a palliative service prior
to hospice care (Kapo, Harrold, Carroll, Rickerson, & Casarett, 2005).
Socioeconomic and Racial Influence on End-of-Life Treatment Decisions
In 2011, Muni et al. published a study which examined how race/ethnicity and
socioeconomic status (SES) may influence end-of-life care for patients in the intensive
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care unit. There is little research on socioeconomic status and end-of-life decisions (Muni
et al., 2011). Prior research was limited on the relationship of socioeconomic status to
end-of-life care decisions (Bach et al., 1999; Barnato et al., 2006; Borum et al., 2000;
Degenholtz et al., 2003; Epstein & Ayayanian, 2001; Muni, et al., 2011). Much of the
available research specific to race and socioeconomic status addresses access issues and
the disparities in the receipt of necessary medical interventions (Bach et al., 1999;
Barnato et al., 2006; Degenholtz, et al., 2003; Epstein & Ayanian, 2001; Farjah et al.,
2009; Fowler et al., 2010; Shavers & Brown, 2002).
Muni et al. (2011) found that SES did not consistently predict end-of life-care
decisions but race/ethnicity did contribute. Their study differentiated race in a crude way
by categorizing patients as either white or non-white. Non-white patients were less likely
to complete advance directives and were more likely to choose life-sustaining treatments
and full code status. This study highlights the limitation of grouping all minorities
together, which made it impossible to detect specific cultural influence amongst different
minority populations (Muni et al., 2011).
Although SES was limited as a predictor of end-of-life decisions, both variables
were significant predictors in the completion of advance directive documents. While
lower SES patients likely avoided completion due to low literacy levels, factors
influenced by race were more complex (Muni et al., 2011). One study on SES (Fowler et
al., 2010) cited higher mortality for those without insurance. In this study, the focus was
not on end-of-life care choices specifically, but rather the lower use of critical care
resources in this population (Fowler et al.). Franks and Fiscella (2002) highlighted the
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performance indicators and medically sought interventions. When evaluating a patient’s
socioeconomic status, SES is difficult to define because data collection in the medical
record excludes education and income. To compensate for this deficiency, Fiscella and
Franks (2001) cited using both zip code and/or geocoded addresses to derive SES.
Though studies of SES as a predictor of end-of-life decisions are few, studies do show
underuse of hospice services in minority neighborhoods (Haas et al., 2007).
End-of-life care practices are shaped by a person’s heritage, surroundings,
religion and family. They are culturally centered. (University of Washington Medical
Center, 2007). Trust in end-of-life care is an ongoing issue, especially among African
American populations. The Tuskegee Syphilis Study is one of the most notorious
landmarks to contribute to the historical trends in the data that help support this claim
(Mitchell & Mitchell, 2009). According to multiple studies, hospice is utilized by Blacks
and other minorities less of the time than by Whites (Cohen, 2008; Haas et al., 2007;
Smith, Earle, & McCarthy, 2009). In research examining why African American culture
influences such life choices, 205 adults were surveyed to discuss the issue of death
(Johnson, Kuchibhatla et al., 2008). Though some themes could be identified, one
absolute cause is not understood. The results concluded that African Americans view
hospice in a more negative light, have religious beliefs which conflict with the
philosophies of palliative care, show an overall lack of trust in medical systems, and are
less likely to be comfortable discussing death or to complete an advance directive
document (Johnson, Kuchibhatla et al., 2008).
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A disconnect remains between African American healthcare and the continuity of
choice for medical interventions (Borum, et al., 2000). In the 2010 study by Johnson and
colleagues, African Americans were less likely to receive an initial intervention to slow
progression of disease, but more likely to continue with the life support. Similar studies
also found that Black patients and their families rated overall end-of-life care quality
lower than White patients (Welch, Teno, & Mor, 2005). African American patients who
died were also younger on average than Caucasian patients (Johnson, et al., 2010). The
national median life expectancy for African Americans remains six years younger than
for Caucasians, which is at least partly explained by disparities in medical interventions
(Epstein & Ayanian, 2001).
Cultural history may factor into this medical care conundrum (Waters, 2001).
There are a limited number of studies measuring specific cultural differences in care level
choices. In a review of the literature, only 13 studies were found on end-of-life decisions
and African American values (Mitchell & Mitchell, 2009). However, the existing
literature consistently identified increased utilization of full code status and life support
services among African Americans (Mitchell & Mitchell, 2009).
African Americans are twice as likely as Caucasian patients to choose full code
status instead of DNR at end of life (e.g., Borum et al., 2000; Johnson et al, 2010).
African Americans are half as likely to withdraw aggressive care (Johnson, 2010). These
decisions have financial implications. Moreover, African Americans averaged 32% more
dollars spent in the end-of-life period, mostly accounted for by funds spent on artificial
support (Hanchate, Kronman, Young-Xu, Ash, & Emanuel, 2009).
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Factors associated with the differences in decisions include faith conflicts, lack of
trust in healthcare, and environmental impacts, such as community influences (Johnson et
al., 2010). Waters (2001) analyzed common themes among African Americans as they
made end-of-life care decisions. These included societal and historical implications,
reliance on family and friends to make decisions, and the impact of spiritual beliefs. One
study specifically looked at the spiritual beliefs of African Americans and their
aggressive care choices. Their research found that African American families often
believed a miracle would result in healing, thought withdrawal was a form of assisted
suicide, and felt that God, and not the medical team should be in control. They therefore
sometimes declined to make decisions to de-escalate care or move to palliation and
hospice (Johnson, Katja Elbert-Avila, & Tulsky, 2005). In an effort to explain the value
and to increase the use of palliative and hospice medicine by the African American
population, the Initiative to Improve Palliative and End-of-Life Care in the African
American Community was created in 2000 (Crawley, et al., 2000). This panel was
designed to improve understanding of cultural implications as applied to healthcare
choices.
Minorities may also experience barriers because of concerns about costs and lack
of education about end-of-life services. In a study of inner-city minorities, participants
voiced the desire to provide care for their loved ones without help from outside entities.
(Born, Greiner, Sylvia, Butler, & Ahluwalia, 2004). Hospice is used less often by both
Hispanics and African Americans, possibly because of the environmental impact and
community influences in a person’s neighborhood (Haas et al., 2007). The Haas et al.
26

study found lower utilization of hospice services by minorities. The authors postulated
that the difference was likely a result of lack of comprehension and understanding of
hospice services (Haas et al., 2007). In a 2011 qualitative study report by Boyd et al.,
patients indicated that faith and community support affected their care decisions more
than information from physicians. Patients said that information based solely from
physicians influenced them only 2% of the time (Boyd et al., 2010).
As a result of the effect of culture and socioeconomic influence on care decisions,
and the continued rise in cultural disparities, there is an institutional push for culturally
competent, patient centered treatment (Babcock & Robinson, 2011; Betancourt, Green, &
Carrillo, 2011). This culturally competent approach aligns the overall palliative initiative
intervention with all dynamics influencing a patient’s decision (Crawley, Marshall, Lo, &
Koenig, 2002). Some hospitals have created staff education initiatives to improve
understanding of a patient and family’s culture. Education on diverse end-of-life practice
beliefs can act as a catalyst for change (University of Washington Medical Center, 2007).
Code Status and Comfort Care Level Issues
End-of life-care in hospitals has been designated “substandard” by the Institute of
Medicine (Edens et al., 2010). These experts suggested that too many patients receive
aggressive care at the end of life unnecessarily, and too many patients die in intensive
care units (ICUs). In 2005, 20% of hospital deaths in the U.S. occurred in the ICU
(Curtis & Rubenfield, 2005). Interestingly, more than 90% of patients who die in an ICU
receive recommendations from the physicians for de-escalation of care, and more than
half of that 90% die after withdrawal or limits to life-sustaining treatments (Curtis &
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Rubenfield, 2005). Aggressive hospital technology is a routine part of end-of-life care,
yet the issues surrounding withholding or withdrawing care are increasing (Johnson et al.,
2010). The World Health Organization (WHO) stated that palliative care is not directed at
hastening death but instead promotes death as a natural process, provides pain and
symptom relief, and supports the bereaved (Edens et al., 2010).
According to one study, about one half of patients expected to live less than six
months were put on life support during the three days prior to death (Bendaly, Groves,
Juliar, Gregory, & Gramelspacher, 2008). Advances in technology often make it hard to
determine when a patient is truly at the end of life, and many issues contribute to this
dilemma (Reynolds et al., 2005). One such issue is the distinction between withholding
and withdrawing treatments. Once treatment has begun, especially if it was the patient’s
decision to begin this course of care, family and clinicians may feel a moral obligation to
continue the treatment. Withdrawal decisions are often made by a surrogate when the
patient is no longer conscious. Furthermore, clinicians often do not make it easier for
caregivers. When they feel uncertainty about prognosis, clinicians may err on the side of
maximizing any “potential benefit,” despite the risk that burdens may outweigh that
benefit (Reynolds et al., 2005 p. 471).
Not all patients will survive their illnesses, despite advanced technologies
(Kirchhoff & Faas, 2007). Critical care unit services have changed greatly over the
years, and the responsibility held by the family for the critical care patient has increased
as the principle of autonomy replaces the strong paternalism that once resonated in
medicine. Patient autonomy allows healthcare professionals to defer to family for
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decision making at the end of life. Withholding or withdrawing treatment is a factor in
almost 70% of deaths that occur in a critical care unit, and consent for these measures
must come from the authorized party (Kirchhoff & Faas, 2007). Making this decision is
a heavy burden for families. Emotions such as guilt, anger, regret, and even the
anticipation of these emotions may act as barriers to letting go (Kirchhoff & Faas, 2007).
Healthcare professionals’ sense of timing as well as their ability to understand the
social influences and emotional state of the authorized party can have a strong impact on
the outcome of consent to withdraw or withhold (Kirchoff & Faas, 2007). Physicians
tend to delay discussions of resuscitation choice until all therapeutic resources have been
exhausted. For example, if a Do Not Resuscitate (DNR) order is discussed before the
attending physician conducts a thorough dialogue about poor prognosis, the family and
patient may be resistant and unable to accept the situation (Kirchoff & Faas, 2007).
Semantics can also “make or break” these sensitive conversations. Vennerman,
Harris, Perish & Hamilton (2008) examined issues of DNR orders versus AND (Allow a
Natural Death) orders. Based on the authorized party’s understanding of these concepts,
there may be meaningful changes in the dialogue and choices made (Tompkins &
Wanka-Thibault, 2001). Families often have difficulty understanding DNR orders. The
idea of DNR may cause greater anxiety for families who associate it with “giving up” and
negative connotations. On the other hand, the use of changed semantics like “Allow a
Natural Death” increased the authorized party’s understanding during explanations of
poor prognosis (Vennerman et al., 2008). Families may be more receptive to the concept
of AND rather than DNR. Because emotional states largely define what a grieving
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family comprehends, it may seem easier to release a loved one and allow nature to take
its course. When phrased as AND, decisions to restrict Cardio Pulmonary Resuscitation
may increase not only among the family members but also among the medical team
(Vennerman et al., 2008).
End-of-life discussions are among the most difficult tasks required of physicians,
largely due to negative attitudes towards dying in Western society (Cartwright, Bregje,
Williams, Faisst, Mortier, Nilstun, et al., 2007). Because it seemingly defeats their goal
of healing, physicians at times do not want to convey a terminal prognosis. However, an
essential part of the care plan is omitted when the patient receives a terminal diagnosis
but end of life is not discussed (Cartwright et al., 2007). Glass and Nahapetypan (2008)
observed that the ongoing barriers to end-of-life conversations between elders and adult
children included family dynamics, issues with trust in surrogate decision-making, a
general inability to determine what patients really wanted, and the fear of death.
During many conferences with family members of terminally ill patients, doctors
do the majority of the talking. Families often experience communication overload, and
they may thus be unwilling or unable to offer feedback. Communication barriers are the
likely result, and emotions factor into this issue (Tompkins & Wanka-Thibault, 2001).
Such sensitive conversations require skills that not all physicians possess, such as gaining
trust, expressing empathy, using opportune moments to discuss issues, and moving both
doctor and family toward a more deliberative relationship (Babcock & Robinson, 2011;
Reynolds et al., 2005).
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Dying patients value symptom management as well as good relationships. Most
persons truly desire to prepare for death, not to prolong it, and they do not want to burden
their loved ones (Ganzini, Johnston, & Silveria, 2002). Communication between patient
and doctor about prognosis and goals of care greatly influences the perceived quality of
end of life. In one study, positive family regard for physicians increased not as a result of
treatment but rather on the basis of how well the physician listened to the needs of the
family and patient (Biola et al., 2007). However, among terminally ill ALS patients,
Ganzini and colleagues (2002) found that physicians did not refer patients to hospice onethird of the time. Specific problems with end-of-life conversations included the initial
efforts at communication of prognosis and expectations for the process of dying, whether
the physician used medical jargon or overestimated the expected life-span leading to false
hope, and how well the physician communicated throughout the illness in face-to-face
meetings with patients and their families (Biola et al., 2007).
Learning how to communicate about death is a vital component of physician
education. Basem and Usta (2006) surveyed fourth-year medical students and asked
about their experiences in giving a poor prognosis and explaining palliation. Of these,
64% finished medical school without ever having watched a senior physician give a
patient a terminal prognosis. Instead, physicians offered bright pictures of hope and did
not include death in the conversation (Basem & Usta, 2006). Gawande (2010) noted that
physicians overestimated the survival of their patients in more than 60% of cases.
Ultimately, the best communication finds a balance between hope and reality of the
progression of the illness (Cartwright et al. 2007).
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Glass and Nahapetyan (2008) described end-of-life care in the U. S. as poor.
America possesses a “…death denying culture…” which creates a barrier to conducting
studies on dying. Likewise, well-facilitated prognosis conversations are avoided.
Consequently, if a conversation is not initiated, a family cannot know their loved one’s
wishes. Surrogates were found to be incorrect in guessing what the patients’ wishes were
for the end of life 30% of the time (Glass & Nahapetyan, 2008). In a 2001 study, preoperative discussions were initiated by anesthesiologists regarding end-of-life care. While
70% of patients did have known wishes pertaining to their medical treatment, only 25%
had spoken to their doctor about their wishes (Grimaldo et al., 2001).
In 1991, Congress passed the Patient-Self Determination Act, which requires
healthcare institutions to ask patients about advance directives. Advance directives allow
a patient to make their wishes for end of life known when they cannot speak for
themselves (Tierny et al., 2001). Although the vast majority of patients support the idea
of completing an advance directive, only 5-15% of patients have these documents
(Grimaldo et al., 2001).
One community has taken this message to heart. In Lacrosse, Wisconsin, 85% of
persons studied post mortem had completed an advance directive (Gawande, 2010). The
Lacrosse project, Respecting Choices, targeted patients with congestive heart failure
(CHF), end stage renal disease, and other illnesses, focusing on advance care planning
(Hammes, 2003). The Lacrosse practice has been successful due to their focus on an
ongoing process of constant discussion surrounding end of life. In addition, they are
averaging cost savings between $3,000 and $6,000 annually per patient, compared with
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historical U.S. averages because of the advance care planning (Gunderson Lutheran,
2010).
However, even under ideal circumstances, not every patient will be able to
complete a written advance directive (Milstein & Raingruber, 2007). If a patient did not
complete an advance directive and can no longer communicate, the family becomes the
source of decision making. Attention should be placed on transition to death for families,
particularly when discussions did not occur prior to the patient’s unconscious state. The
literature supports shared decision making between the physician and the family with
quality end of life as the primary focus (Milstein & Raingruber, 2007).
It is important to consider what patients and families may be experiencing. Their
emotions may affect their ability to process what is being explained (McSherry, Kehoe,
Carroll, Kang, & Rourke, 2007). Palliative care uses the multidisciplinary approach to
meet the needs of the family, with discussions centered on patient wishes, quality of life,
advance care planning, and needed support for all involved (Babcock & Robinson, 2011;
Fineberg, 2005).
According to Menkin (2007), tools such as cards that rank quality of life have
been developed to aid professionals with end-of-life care decisions. However, the
palliative team likely remains the best tool for communication. In the Transitions
palliative model developed by MCCG, communication is the cornerstone of decision
making (Babcock & Robinson, 2011). In their groundbreaking article in the Journal for
Palliative Medicine, Babcock and Robinson (2011) delineated the critical components of
their counselor-initiated model. Transitions Counselors assess the whole patient situation
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by considering barriers, family availability, differing points of view, health literacy,
language, age, family hierarchy, quality of life, advance directives, and cultural and
spiritual impacts. This assessment often requires multiple meetings with family members
and often entails several hours of quality communication prior to the actual consultation
with the palliative care physician. The success of the consult is found in the education
provided and the communication process, regardless of the choices made for end-of-life
care. Even after all the information is given, the patient and family may choose death on
artificial support as representative of their autonomy and values at end of life. This
unique palliative model systematically identifies and assesses potential barriers to
communication often before they occur (Babcock & Robinson, 2011).
Costs at End of Life
End-of-life care, defined in this paper as care for the terminally ill patient,
constitutes 27% of the Medicare budget in the U. S. (Hogan, Lunney, Gabel, & Lynn,
2001). Experts expect that the elderly, ill and dying populations will double in the next 15
years (Appleby, 2006). No appropriate level is known for spending at end of life, and
values about quality of life at end of life are different for everyone. However, many
populations with both chronic and acute illness could benefit from a better, more cost
efficient care plan, especially those with terminal illness (Luce & Rubenfield, 2002).
Medicaid recipients also incur high costs for medical care at the end of life which
might be drastically reduced by organized palliative care interventions. Research by
Morrison et al. (2011) showed an approximate $6,900 reduction per admission, per
patient using palliative care. However, spending as a disease advances appears “U34

shaped, rising again toward the end” (Gawande, 2010, p. 3). The inability of
government-funded agencies to assess expanding medical technologies in a financially
efficient manner may contribute to the rising costs (Luft, 2009).
A well-designed palliative model may reduce costs by several thousand dollars
per admission (Crawford, 2011; Spugnardi, 2008). Major cost savings come from fewer
tests and decreased critical care utilization (Morrison et al., 2008). For example, one
study examined a palliative program for patients admitted to the hospital with chronic
pain. When correct palliative care was used to standardize a patient’s symptom
management, more than $2 million were saved (Morrison et al., 2008). Other research
suggests that at least 10% is saved by palliative care, and up to 20% is saved, when
comparisons are made to cases with a higher length of stay (Hanson, at al., 2008). The
National Framework and Preferred Practices for Palliative and Hospice Care Quality
Consensus Report added that palliative services can be deemed a best practice and lead to
enhanced performance (National Quality Forum, 2006).
The difficulty of identifying palliative savings is the challenge of using an
appropriate measurement tool to determine avoided costs. One way to identify savings is
to compare palliative patients to non-palliative (Hanson et al., 2008), though this has
limitations because of the variability in case complexities. In one study, non-palliative
and palliative total costs were compared along with Diagnostic Related Group (DRG)
coding to adjust for disease complexity. Palliative patients averaged $35,824 per hospital
stay, compared with $42,731 for non-palliative patients (Bendaly et. al., 2008).
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The Quality-Adjusted Life Year model (QUALY) is one financial model which is
currently utilized for cost reduction. Wright (2009) questioned whether the QUALY,
utilized by other countries as a tool for cost reduction at the end-of- life could truly
determine quality of a person’s life. Allocation of resources at end of life seems to occur
more readily in other countries than in the U.S (Wright, 2009). Research shows that
evidenced-based allocations of resources may decrease cost by 38% (Gunes & Yaman,
2005). Much of the ethical debate in American healthcare involves inequity of costly
resources given to patients who may not benefit (Newbold, Eyles & Birch, 1995). Cost
effective analysis attempts to use the QUALY scale by assessing the benefit of a
therapeutic measure based on years of life combined with health related quality of life
measurements (Gunes & Yaman, 2005). Research suggests that cost reductions are best
accomplished in critical care units due to the expense of this environment. Cost
reductions depend on lower use of potentially life-sustaining treatments for patients with
terminal illnesses (Luce & Rubenfield, 2002).
Decreasing length of stay (LOS) may prove cost efficient when the overall
hospital stay decreases or LOS in a medical intensive care unit goes down (Norton et al.,
2007). The Center for the Advancement of Palliative Care (CAPC) has conducted a
study to assess the reasons behind prolonged LOS. The CAPC proposes user-friendly
templates to prove financial savings on length of stay and days saved (Meier &
Beresford, 2008).
There is a national initiative to reduce overall mortality rates in hospitals. This
initiative views mortality in a hospital as an avoidable adverse event, which may conflict
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with a palliative approach which views death as an expected and normal outcome
(Institute for Healthcare Improvement, 2005).
Summary
End-of-life care is expensive (Zhang, et al., 2009; Emanuel & Emanuel, 1994;
Luce & Rubenfield, 2002). Some researchers have argued this is attributable to U.S.
culture, while others postulated that effective advancements in medical technology inhibit
the ability to grasp prognosis (Glass & Nahapetyan, 2008; Reynolds, et al., 2005). No
appropriate level is known for spending at end of life, and values in quality of life at end
of life differ with each individual. Historical trends for end of life document sustained
high costs in the last year of life (Emanuel & Emanuel, 1994; Luce & Rubenfield, 2002).
However, despite increasing use of aggressive hospital technology at the end of life,
withholding and withdrawing care are also increasingly common (Johnson et al., 2010;
Norton, et al., 2007; Spugnardi, 2008; Morrison et al., 2011)
Dying patients value symptom management and good relationships with their
physicians. Most truly desire to prepare for death and not to prolong it. They do not want
to burden their loved ones (Ganzini et al., 2002). Communication between patient and
doctor about prognosis and goals of care directly impacts the quality of a patient’s endof-life experience (Biola, et al., 2007).
Muni et al., (2011) found that socioeconomic status did not consistently predict
end-of life-care decisions but that race/ethnicity may be a more powerful contributor.
Trust in end-of-life care is an ongoing issue, especially amongst African American
populations. African Americans seem to view hospice in a more negative light, as they
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sometimes have religious beliefs that conflict with the philosophies of palliative care,
have less trust in medical systems, and are less likely to be comfortable discussing death
or to complete advance directives (Johnson et. al., 2008). Cultural and socioeconomic
influences continue to be an understudied area of the literature (Mitchell & Mitchell,
2009; Muni, et al., 2011).
There are numerous studies on the positive effects of palliative care (Edens et al.,
2010; Gade, et.al, 2008; Temel et al., 2010). Researchers have proven that appropriate
palliative and hospice care at end of life can lengthen life in comparison to aggressive
care without palliation (Temel et al., 2010; Gawande, 2010). Palliative care is a
multidisciplinary approach to the relief of symptoms and suffering and the improvement
of overall quality of life during illness. This care is patient and family centered.
Palliative care consultation includes a discussion surrounding long term goals of the
patient, including advance care planning and/or care at the end of life(Griffin et al.,
2007). The success of the consult is in the education provided and communication
process, regardless of the choices made for end-of-life care. Even after all the information
is given, the patient and family may choose death on artificial support to be
representative of their autonomy and values at end of life (Babcock & Robinson, 2011).
In a 2008 survey of hospital based palliative programs, Georgia was ranked on the
lower end of average, with 20% to 40% of hospitals recorded as having these programs
(Goldsmith at al., 2008). There are many variations in hospital palliative program
models (Meier & Beresford, 2006), the most common being the consultation model
(Meier & Beresford, 2007). There is a national recommendation, for hospital-based
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palliative programs to coordinate closely with hospice (Meier, 2005). Palliative care
programs in the hospital setting meet some of the limitations of hospice inadequacies,
providing a smoother transition from hospital to hospice (Gade et al., 2008). In one study,
72% of patients who were discharged alive from a hospital-based palliative program were
discharged to hospice (Santa-Emma et al., 2002). Several studies have documented the
cost savings and decreases in length of stay which result from palliative care in the
hospital (Bendaly et al., 2008). While not all hospitals have palliative program, the
majority of hospitals with 50-plus beds, have a well-established program and benefit
from the services (Morrision et al., 2005).
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CHAPTER 2
RESEARCH QUESTIONS AND HYPOTHESES
Research Questions
The following research questions were explored:
#1: Is there a difference in code status pre and post palliative intervention?
a. according to gender
b. according to race
c. according to age
d. according to education (socioeconomic status)
e. according to income (socioeconomic status)
f. according to payer source (socioeconomic status)
g. according to disease distribution
#2: Is there a difference in Stage IV, (comfort measures status) pre and post
palliative intervention?
a. according to gender
b. according to race
c. according to age
d. according to education (socioeconomic status)
e. according to income (socioeconomic status)
f. according to payer source (socioeconomic status)
g. according to disease distribution
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#3: Is there a difference in number of discharges to hospice following a palliative
intervention?
a. according to gender
b. according to race
c. according to age
d. according to education (socioeconomic status)
e. according to income (socioeconomic status)
f. according to payer source (socioeconomic status)
g. according to disease distribution
#4: Is there a difference in cost of care by length of stay pre and post palliative
intervention?
a. according to gender
b. according to race
c. according to age
d. according to education (socioeconomic status)
e. according to income (socioeconomic status)
f. according to payer source (socioeconomic status)
g. according to disease distribution
#5: Is there a difference in cost per days saved post palliative intervention?
a. according to gender
b. according to race
c. according to age
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d. according to education (socioeconomic status)
e. according to income (socioeconomic status)
f. according to payer source (socioeconomic status)
g. according to disease distribution
h. according to hospice
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Hypotheses
In addition, the following hypotheses were tested:
#1: No statistical differences will be detected relative to code status pre and post
palliative intervention.
a. according to gender
b. according to race
c. according to age
d. according to education (socioeconomic status)
e. according to income (socioeconomic status)
f. according to payer source (socioeconomic status)
g. according to disease distribution
#2: No statistical differences will be detected relative to Stage IV comfort
measures pre and post palliative intervention.
a. according to gender
b. according to race
c. according to age
d. according to education (socioeconomic status)
e. according to income (socioeconomic status)
f. according to payer source (socioeconomic status)
g. according to disease distribution
#3: No statistical differences will be detected relative to hospice discharge post
palliative intervention.
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a. according to gender
b. according to race
c. according to age
d. according to education (socioeconomic status)
e. according to income (socioeconomic status)
f. according to payer source (socioeconomic status)
g. according to disease distribution
#4: No statistical differences will be detected relative to cost of care per length of
stay post palliative intervention.
a. according to gender
b. according to race
c. according to age
d. according to education (socioeconomic status)
e. according to income (socioeconomic status)
f. according to payer source (socioeconomic status)
g. according to disease distribution
#5: No statistical differences will be detected relative to cost of care per days
saved post palliative intervention.
a. according to gender
b. according to race
c. according to age
d. according to education (socioeconomic status)
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e. according to income (socioeconomic status)
f. according to payer source (socioeconomic status)
g. according to disease distribution
h. according to hospice discharge
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CHAPTER 3
METHODS
Purpose of the Study
The purpose of this study was to examine differences in treatment level at the end
of life according to socioeconomic status and race. Data included treatment level
measurements before and after the palliative intervention from a secondary data set.
Further, this study looked at the influence of socioeconomic status and race on code
status, comfort measures, discharge, and costs, for patients at the end of life who had
experienced the palliative program.
This chapter is organized into the following sections to profile study methods: (1)
design of the study; (2) sampling plan; (3) instrumentation; (4) collection and treatment
of data; and (5) analysis and interpretation of data.
Design of the Study
This study was a quantitative research design which utilized pre-determined
retrospective performance data. Variables under study were assessed via a cross-sectional
research design (Creswell, 2010). The palliative intervention was defined as a clinical
assessment and family conference with a palliative practitioner and a counselor from the
MCCG Transitions Palliative Care Team. The intervention was a dependent variable for
the total population targeted. All sample population participants had received the baseline
intervention defined above prior to post measurements.
Independent, predictor variables included race, gender, age, socioeconomic status,
and disease. Race was categorized as Caucasian, African American, other, and unknown.
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Other included outlier races. Two variables were used to determine socioeconomic status.
These included address and payer source. Address was used to determine education and
income level through the geocoding mechanism. The geocoding software provided
mapping technology to define the subdivisions within a census tract. The census tract
defined the socioeconomic status. (Chen et al., 1998). Payer source was grouped into
categories of insured and underinsured and helped determine socioeconomic status for
those patients with an unidentifiable address (Muni et al., 2011).
Dependent outcome variables included pre and post measurements for dying with
quality and comfort measures. More specifically, these variables included code status pre
and post palliative intervention, comfort measure status pre and post palliative
intervention, discharge distribution to hospice, and cost categorized by length of stay
(LOS), pre and post intervention.
Patient age, patient sex, and disease distribution were included in regression
analysis. Age was categorized using the National Registry for Palliative Care, and
categories included ages 2-17, 18-65, and 65 plus. Minors were removed after
categorizing for protection of a vulnerable population. Disease distribution was split into
two categories of cancer and no cancer based on National Palliative Registry data
reporting (CAPC, 2009).
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Sampling Plan
This study served as a secondary analysis of a unique clinical database at the
Medical Center of Central Georgia (MCCG). MCCG started their palliative program in
2004 under the direction of the Center for the Advancement of Palliative Care (CAPC)
and through the use of the Transitions and Palliative Care Therapy Model (TPCT)
(Babcock & Robinson, 2011). Currently, there are more than 11,330 patients who have
been admitted to the program (Babcock & Robinson, 2011). This research utilized data
from patients from the years 2008-2010 because data the instrument was consistent from
2008. As an end date for sample data, December 31, 2010, was chosen to ensure that no
active patients were included in the data set. All patients entered into the database for
these three years, with the exception of five minor patients, were eligible for this study.
N=2,920 patients was the target population and sample.
Instrumentation
The data for this study was extracted from a unique clinical database. The
Footprints database was used to record data from patients admitted to the palliative
program at MCCG. MCCG began using Footprints in the summer of 2006. Access to
patient charts allowed for accurate data to be entered directly into the system before and
after a palliative intervention. The database included demographic, socioeconomic,
disease distribution, and treatment status fields. New fields were added to the instrument
up until 2008, from which point the instrument remained consistent. Hence, a data
collection period of 2008-2010 was chosen. Since this was a secondary data analysis, no
new instrument was used to collect further data. The Principal Investigator did not have
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access to the medical record. However, the medical record was used by a third party at
MCCG to retrieve any missing data, including payer source.
Collection and Treatment of the Data
This research was approved by the Georgia Southern University Institutional
Review Board (IRB) and approved by the Medical Center of Central Georgia IRB
representative. The authorized facility key informants were contacted prior to the study to
ask for their participation, and a data cooperation agreement was proposed. The Principal
Investigator also went through the necessary steps to become a Medical Center of Central
Georgia doctoral intern including orientation, compliance education, health screenings
and photo identification process. This was to ensure protection and privacy of the patients
studied. A secondary data agreement was also executed and signed by the cooperating
facility, MCCG.
The Principal Investigator looked at data retrospectively. Data collection occurred
between 2004 and 2010. However, the Footprints database was used from 2006 and 2010.
Fields were added up until 2008. Therefore, data were limited to the more recent years.
Duplicated patients were marked by last visit to determine whether a change ultimately
occurred after the intervention. Data was de-identified for the protection of patient
privacy. De-identification took place through the use of the unique clinical identifier
number, and finally through coded identity. Patients were coded, patient 1, patient 2
continued.
Data was extracted, cleaned and coded from patient medical records and the
Footprints clinical database by a trained third party working with the Principal
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Investigator to ensure objectivity and patient privacy. This assured compliance with the
terms set forth by the Georgia Southern University Institutional Review Board and the
MCCG secondary data agreement. Data were linked from both data sources using a
unique clinical identifier which aligned with the medical record number for verification.
Data were cleaned and coded into descriptive fields which included age by category, sex,
and disease distribution by category. Dependent variable fields were cleaned and coded
into race and payer source. Address was not coded for verification reasons and to allow
for geocoding following initial coding.
Geocoding acted as a surrogate indicator of the patient’s socioeconomic status
and ultimately defined elements of income and education through the process of a three
level processing system and GIS Arch 10.0 software. The addresses were cleaned into
fields of street number and name, zip code and unique patient identifier. Addresses were
processed through the GIS software to map the address to the point. A shapefile for each
of the eight designated counties, including Bibb and surrounding rural areas, Baldwin,
Crawford, Houston, Jones, Monroe, Peach, and Twiggs Counties were cross matched to
define the census tract for each point. Population data was processed and downloaded
from the census.gov site for each of the eight counties and formatted to be cross matched
with the GIS mapped tracts. From this point, the data was imputed back into the original
set and each mapped address was assigned a known census tract, income and education
level. Income and education variables were then coded categorically.
Outcome variable fields were cleaned and coded into code status, pre and post
intervention; comfort measure status, pre and post intervention; death and discharge; and
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discharge to hospice. Cost was coded and categorized by length of stay (LOS), pre and
post intervention, and a mean days saved variable was identified. Categories for LOS
were based on outside literature (e.g., Klein, Ross, Adams, & Gilbert, 1994). Further, a
cost assessment was completed using the literature and tools suggested by the Center for
the Advancement of Palliative Care (CAPC, 2008).
Analysis and Interpretation of the Data
The data was analyzed in multiple phases. Lone predictor variables were analyzed
to determine care level outcomes as a matched pair design in a 2-by-2 table format using
the McNemar test for symmetry (Norman & Streiner, 2000). The Likelihood Ratio Chi
Square test was used to determine discharge to hospice. In order to further examine
differences in end-of-life treatment measures further, and the association between
variables and care levels, multivariate analysis was used in a Logistic Regression test.
Logistic regression was used for cross sectional, retrospective data (Lachin, 2000).
McNemar-Bowker tests were used to determine length of stay before and after the
intervention. Finally, the t-test was used to look at the comparison of means in days
saved, and Bonferroni in conjunction with ANOVA was used to analyze days saved
relative to the hospice predictor variable. (Norman & Streiner, 2000).
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CHAPTER 4
RESULTS
The purpose of this study was to examine differences in treatment level at the end
of life according to socioeconomic status and race following a palliative care
intervention. Data included treatment level measurements before and after the palliative
intervention using a secondary data set. Length of stay and days saved aligned with
treatment level were also examined relative to socioeconomic status and race.
This chapter is organized into the following sections to present the study results:
(1) sample characteristics; (2) explanation of the geocoding process; (3) analysis of
research questions and hypotheses; (4) systemic sample; (5) summary of results.
Sample Characteristics
Data from 2,920 patients were used for this analysis from a pre-collected database
where collection had occurred while the patients were actively admitted into the Medical
Center of Central Georgia (MCCG). Patients were chosen based on requirements set by
the researcher from a pre-determined data set from years 2008-2010. Participants of the
study represented patients from different demographic categories as profiled in table 4.1.
Six descriptive, demographic variables were included as potential predictors of treatment
options. Variables included gender, race, age, education level, income level, the patient’s
payer source and their disease. Outcome variables for which pre and post measurements
were taken included code status, no code to full code and full code to no code, care level
status from aggressive to comfort care and from comfort to aggressive care as profiled in
table 4.2. The post measurements were taken following the palliative intervention.
Hospice discharge was measured for all patients. This included whether or not the patient
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was admitted to hospice on discharge and the mortality of patients in the hospital. Lastly,
measurements were taken on length of stay pre and post palliative intervention and days
saved as a result of the intervention.
Female patients accounted for 1,473 (51.8%) of the participant population and
males accounted for 1,362 (47.9%) of the participant population. Eight (.3%) of the
charts were missing gender information. For the purpose of this study and because of
limited information on other minorities, the study only included racial categories of
White 1,432 (50.4%) and Black 996 (35%), whereas all unknown, missing and other
races 415 (14.6%) were not included in the analysis. Age was defined in categories of
18-65 for 934 (32.9%) of patients and over 66 for 1,786 (62.8%) patients. Minors were
not included in the sample and there were 123 patients (4.3%) whose age was missing or
unknown. Socioeconomic status was defined through variables of education, income and
payer source. Education was determined through the process of geocoding explained
below, and divided into categories of less than high school 351 (12.3%), high school
diploma, 1,054 (37.1%) and college, 339 (11.9%). Some patients, 1,099 (38.7%) were
missing education information because no census match was achieved by address.
Income levels were split into categories of <$10,000 annually for 97 (3.4%),
$10,000-29,999 annually for 687 (24.2%), $30,000-49,999 annually for 121 (4.3%),
$50,000-74,999 annually for 28 (1%) and >$75,000 annually for 568 (20%). Again,
missing data was most prevalent in income categories accounting for 1,342 (47.2%) of
patients who could not be matched by address. Categories of payer source included the
insured 2,323 (81.7%) defined as those patients with Medicare, private insurance and
veterans sources and the underinsured 520 (18.3%) defined as those with Medicaid, no
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insurance, self pay or unknown. Disease distribution categories included cancer, 641
(22%) non-cancer patients, 1,989 (68%), and missing disease distribution for 285 (10%)
of patients.
Table 4.1
Sample patient characteristics
Variable
Gender Female
Male
Missing
Race
White
Black
Missing
Age
18-65
66 and older
Missing
Education Less than HS
HS Diploma
College
Missing
Income Less than 10,000

N
1473
1362
8
1432
996
415
934
1786
123
351
1054
339
1099
97

Percent
51.8%
47.9%
0.3%
50.4%
35%
14.6%
32.9%
62.8%
4.3%
12.3%
37.1%
11.9%
38.7%
3.4%

687
121
28

24.2%
4.3%
1.0%

75,000 or more
Missing
Pay Source Insured
Under insured

568
1342
2323
520

20.0%
47.2%
81.7%
18.3%

Disease Distribution
Cancer
No Cancer
Missing

641

22%

10,000-29,999
30,000-49,999
50,000-74,999

1,989 68.2%
285
10.2%

Outcome variables profiled in table 4.2 show N= number of total patients for each
category and percentage of patients relative to code status, comfort/aggressive measures,
discharge to hospice, mortality rates and length of stay for the total population. Data in

54

this table does not differentiate according to predictor variables, but rather looks at
outcomes for the total population before and after the palliative intervention.
Before the palliative intervention 772 patients (27.2%) of patients were DNR or
no code status and 2,071 (72.8%) were full code status. After the intervention, the vast
majority 2,344 (82.4%) of patients were made DNR or no code and 499 (17.6%) of
patients remained a full code. There were 130 (4.6%) of patients receiving comfort care
prior to the intervention and 2,713 (95.4%) receiving aggressive care. Following the
intervention, 1,232 (43.3%) changed to comfort measures, while 1,611 (56.7%) continued
to receive some aggressive measure. After the intervention, discharge measurements
showed that 493 (17.3%) of patients used hospice care, 481 (16.9%) did not use hospice,
1,515 (53.3%) died in the hospital with hospice or palliation only, and there was missing
data for discharge on 354 (12.5%) of patients.
Finally, in table 4.2 length of stay before and after the palliative intervention was
measured. Before palliative involvement categories of 0-6 days show 1,665 (58.6%), 714 days for 550 (19.3%) patients, 15-21 days for 127 (4.5%) patients and outliers >21
days for 352 (12.4%) of patients. There was missing data on length of stay before the
consult for 149 (5.2%) of patients. Following the intervention, length of stay measured as
follows. The most prevalent post length of stay measure was 0-6 days for 2,100 (73.9%)
patients. There were 438 (15.4%) patients whose length of stay was 7-14 days. Patients
with a length of stay 15-21 days decreased to 77 (2.7%) and patients with >21 days
decreased to 115 (4%). There were 113 (4%) of patients with missing data.
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Table 4.2
Sample outcome variables
Variable
Prior Code DNR
Full
Ending Code DNR
Full
Prior Comfort Comfort only
Aggressive
D/C Comfort Comfort only
Aggressive
Mortality
Died hosp.
Discharged prior
Hospice D/C Used after
No Hospice
Died in hosp.
Missing
LOS before 0-6
7-14
15-21
> 21
Missing
LOS after
0-6
7-14
15-21
> 21
Missing

N
772
2071
2344
499
130
2713
1232
1611
1515
1328
493
481
1515
354
1665
550
127
352
149
2100
438
77
115
113

Percent
27.2%
72.8%
82.4%
17.6%
4.6%
95.4%
43.3%
56.7%
53.3%
46.7%
17.3%
16.9%
53.3%
12.5%
58.6%
19.3%
4.5%
12.4%
5.2%
73.9%
15.4%
2.7%
4.0%
4.0%

Geocoding to Define Socioeconomic Status
Whereas race, age and gender variables were taken at face value from medical
records and the footprints data source, income and education level was derived from the
address included in the patients’ medical records. This required use of Arch GIS
software, 10.0. Patients were de-identified with a unique identifier number for
verification and addresses from the chosen surveillance area were imputed into the GIS
software. The surveillance area was identified based on the majority MCCG patient
population. These counties included Bibb County where MCCG is located and the
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surrounding counties of Baldwin, Crawford, Houston, Jones, Monroe, Peach and Twiggs,
as profiled in table 4.3. If the software was able to match the address to a point in the
surveillance area, the census tract was identified. Census tracts are a geographic division,
which in decreasing order fall below state and county to smaller divisions for heightened
specificity and lower margin of error (Chen et al, 1998).
Blocks and block groups are smaller than census tracts but were not obtainable
using the variables at an acceptable margin of error (Skinner, J Atlanta Regional
Commission, 8/3/2011). The tract data was then merged with the American Community
Survey 2005-2009 census data for Georgia counties, socioeconomic information (US
Census Bureau, 7/28/11). In addition to processing the information for each county,
social and economic information for the Georgia population overall was processed. In
Georgia, 8.3% of households make less than $10,000 annually, a little over 50% make
under $50,000, and 18.8% make $50,000-$74,999 annually. This computes to almost
70% of the state population making under $75,000 annually. Higher income categories
range from 3.7-12% of the population in Georgia, but did not represent a significant
majority of this patient population (US Census Bureau, 8/3/11).
Education averages from Factfinder showed 10.8% of the state population having
received a less than high school education. There are 29.7% of Georgians who have high
school equivalency and 53.2% who have some college which may include associate to
graduate level (US Census Bureau, 8/3/11).
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Figure 4.1. Geocoded Addresses Mapped
Population information was processed using variables for income and education
level for each of the named counties. Stratification was set by the US census bureau.
Income was stratified by county, tract and race. Education level was stratified by county,
tract, and by gender for adults over the age of twenty-five. In the census population data
there were 100-plus different categories of variables for education and income. For
example, within the education variable there were variable divisions for nursery school
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for females over the age of twenty-five up to graduate degrees. Because of the high
number of divisions in Factfinder, the Principal Investigator combined variable categories
for the purpose of this study. Counties had such a wide array of diversity and margin of
error for income and education levels such that no acceptable mean could be achieved by
combining the eight counties. Each patient was looked at within their own tract.
The census tract number identified through the geocoding process was then
matched back to the population data and imputed into the patient dataset. Address was
not always known for every patient and further, some addresses included lot numbers,
P.O. box numbers, nursing homes, transferring facilities and other errors making some
addresses unidentifiable and without match. For this reason, socioeconomic status under
the auspices of income and education was limited to n= 1,794 total matches. The margin
of error varied dependent upon the county and the variable measured. Inferences were
made by using known patient race and sex combined with the coordinating measurement
within the tract.
Analysis of the Research Questions and Hypotheses
The prospective cross-sectional large sample data in this study were analyzed
using the McNemar test of symmetry for matched pairs of full code to no code and no
code to full code before and after the palliative intervention. The McNemar test was also
used to match pairs of comfort to aggressive care and aggressive to comfort care prior to
and following the intervention. A 2-by-2 table format was used and data were treated as a
paired observation.
Following the test of symmetry a multivariate analysis was conducted through a
logistic regression model to look at multiple exposure or predictor variables to determine
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which would have impact on outcomes of code status change and change to comfort or
aggressive measures.
Research Question #1
Is there a difference in code status pre and post palliative intervention?
Null Hypothesis #1
No statistical differences will be detected relative to code status pre and post
palliative intervention?
McNemar's test was used to test for symmetry in change yielding a p-value
<0.0001, indicating significance. The McNemar analysis was run to see if the change
from full code to no code was the same as the change from no code to full code. As
profiled in table 4.3 the change from full code to no code is 55.4% as compared to 0.1%
changing from no code to full code. Thus the intervention has both statistical
significance and a clinical impact on code status. The odds ratio for a matched pair
design is OR=575 with a 95% confidence interval (169, 1620). This means that the odds
are about 575 times greater to change to Do Not Resuscitate.
Table 4.3
Total population code status change following the intervention
After
Full Code
No Code
Before
Full Code
496(17.4%)
1575 (55.4%)
No Code
769 (27%)
3 (0.1%)
499
2344
Total

Total
2071
772
2843

Research Question # 1a
Is there a difference in code status according to gender pre and post palliative
intervention?
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Hypothesis #1a
No statistical differences will be detected by gender relative to code status pre and
post palliative intervention?
The McNemar Test to test for symmetry in change yielded a p-value<.0001 for
both males and females when only gender was used as a predictor variable to look at code
status changes. As profiled in tables 4.4 and 4.5, the change from full code to no code
was 53.4% as compared to a 0.1% change from no code to full code in females. Among
males, there was a 57.6% change from full code to no code as compared to a 0.1%
change from no code to full code. For females, the odds ratio for a matched pair design is
OR=393 with a 95% confidence interval (98, 1574). For males, the odds ratio for a
matched pair design is OR=785 with a 95% confidence interval (110, 5579). The
intervention has both a statistically significant difference and a clinical impact on code
status for both males and females, with minimal difference detected between the two.
Table 4.4
Code status change according to gender-females
Female
After
Full
Code
No Code
Before
Full Code
256(17.4%)
786(53.4%)
No Code
429(29.1%)
2(0.1%)
258
1215
Total

Total
1042
431
1473

McNemar's p<0.0001; OR= 393 with 95% C.I. (98, 1574)

Table 4.5
Code status change according to gender-males
Male
After
Full Code
No Code
Before
Full Code
239(17.5%)
785(57.6%)
No Code
337(24.7%)
1(0.1%)
240
1122
Total
McNemar's p<0.0001; OR= 785 with 95% C.I. ( 110, 5579)

Research Question #1b- Race
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Total
1024
338
1362

Is there a difference in code status according to race pre and post palliative
intervention?
Hypothesis #1b
No statistical differences will be detected by race relative to code status pre and post
palliative intervention?
The McNemar Test to test for symmetry in change yielded a p-value<.0001 for
both Black and White using only race as a predictor variable to look at code status
changes as profiled in tables 4.6 and 4.7. These showed the change from full code to no
code was 56.7% as compared to a 0.1% change from no code to full code in Blacks with
the odds ratio for a matched pair design of OR= 565 with a 95% confidence interval
(79,4018). Among Whites, there was a 55.2 % change from full code to no code as
compared to a 0.1% change from no code to full code with an odds ratio for a matched
pair design of OR=396 with a 95% confidence interval (99,1584) as profiled in table 4.8.
Table 4.6
Code status change according to race-Blacks
Black
After
Full
Code
No Code
Before
Full Code
220(22.1%)
565(56.7%)
No Code
210(21.1%)
1(0.1%)
221
775
Total

Total
785
211
996

McNemar's p<0.0001; OR= 565 with 95% C.I. (79, 4018)

Table 4.7
Code status change according to race-Whites
White
After
Before
Full Code
No Code
Full Code
173(12.1%)
791(55.2%)
No Code
466(32.5%)
2(0.1%)
175
1257
Total
McNemar's P<0.0001; OR= 396 with 95% C.I. ( 99, 1584)
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Total
964
468
1432

The intervention has both a statistically significant and a clinical impact on code
status for both Black and Whites with differences detected.
Research Question #1c
Is there a difference in code status according to age pre and post palliative
intervention?
Hypothesis #1c
No statistical difference will be detected by age relative to code status pre and post
palliative intervention?
The McNemar Test to test for symmetry in change yielded a p-value<.0001 for
ages 18-65 and 66-plus when only age was used as a predictor variable to look at code
status changes between categories of 18-65 and 66-plus as profiled in tables 4.8 and 4.9.
Tests showed the change from full code to no code was 57.7% as compared to a 0.2%
change from no code to full code in those aged 18-65 with an odds ratio for a matched
pair design of OR=269 with a 95% confidence interval (67,1080). Among those aged 66plus, there was a 54.5% change from full code to no code as compared to a 0.1% change
from no code to full code with an odds ratio for a matched pair design of OR=974 with a
95% confidence interval (137,6921) as profiled in table 4.9.
Table 4.8
Code status change according to age- 18-65
18-65
After
Full Code
No Code
Before
Full Code
227(24.3%)
539(57.7%)
No Code
166(17.8%)
2(0.2%)
229
705
Total
McNemar's p<0.0001; OR= 269 with 95% C.I. (67, 1080)
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Total
766
168
934

Table 4.9
Code status change according to age- 66+
66+
After
Full Code
No Code
Before
Full Code
242(13.5%)
974(54.5%)
No Code
569(1.9%)
1(0.1%)
243
1543
Total

Total
1216
570
1786

McNemar's P<0.0001; OR= 974 with 95% C.I. ( 137,6921)

The intervention has both statistical significance and a clinical impact on code
status for both the 18-65 and the 66-plus group with differences detected.
Research Question #1d- Socioeconomic Status
Is there a difference in code status change according to education level pre and post
palliative intervention?
Hypothesis Question #1d- Socioeconomic Status
No statistical difference will be detected by education relative to code status pre and
post palliative intervention?
The McNemar Test to test for symmetry in change yielded a p value<.0001 for
less than high school, high school, and college categories using only education level as a
predictor variable for some of the categories to look at code status changes as profiled in
tables 4.10, 4.11, and 4.12. Patients with less than high school showed the change from
full code to no code was 55% as compared to a 0 change from no code to full code. An
OR could not be computed because of the zero value and no confidence intervals were,
therefore computed. In patients with a high school diploma there was a 55.7% change
from full code to no code and a 0.2% change from no code to full code or equivalent of
an odds ratio for a matched pair design of OR= 292 with a 95% confidence interval
(73,1168). Among those patients with some college and beyond, there was a 51.9 %
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change from full code to no code but a 0 change from no code to full code with an
inability to compute odds ratio or an overall confidence interval because of the zero
value, as profiled in table 4.12. This analysis shows some clinical impact and
significance.
Table 4.10
Code status change according to education level: less than high school
Less than High
After
Total
School
Full Code
No Code
Before
Full Code
68(19.4%)
261
193(55.0%)
No Code
90(25.6%)
90
0
68
283
351
Total
McNemar's p<0.0001; OR= cannot compute with 95% C.I. (cannot compute)

Table 4.11
Code status change according to education level: high school diploma
High School
After
Total
Diploma
Full Code
No Code
Before
Full Code
175(16.6%)
758
583(55.7%)
No Code
294(27.9%)
296
2(0.2%)
177
877
1054
Total
McNemar's P<0.0001; OR= 292 with 95% C.I. (73,1168)

Table 4.12
Code status change according to education level: college
College
After
Full Code
No Code
Before
Full Code
54(15.9%)
176(51.9%
No Code
109(32.2%)
0
54
285
Total

Total
230
109
339

McNemar's P<0.0001; OR= cannot compute with 95% C.I. ( cannot compute )

Research Question #1e- Socioeconomic Status
Is there a difference in code status change according to income pre and post
palliative the intervention?
Hypothesis #1e- Socioeconomic Status
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No statistical difference will be detected by income relative to code status pre and
post palliative intervention?
The McNemar Test to test for symmetry in change yielded a p value<.0001 for all
income levels for those categories computed when only income was used as a predictor
variable to look at code status changes in categories of <$10,000, $10,000-29,999,
$30,000-49,999, $50,000-74,999 and >$75,000 as profiled in tables 4.13-4.17. No
computations could be completed for those in categories of <$10,000, $30,000-49,999
and $50,000-74,999 because of the 0 value which would not allow for an OR to be
computed. Patients making $10,000-29,999 showed a change from full code to no code
was 57.1% as compared to a 0.1% change from no code to full code with an odds ratio
for a matched pair design of OR=392 with a 95% confidence interval (55,2790). Among
those patients with an income > $75,000 , there was a 49.5% change from full code to no
code as compared to a 0.2% change from no code to full code with an odds ratio for a
matched pair design of OR=281 with a 95% confidence interval (39,2000). This analysis
shows the intervention has clinical impact and significance.
Table 4.13
Code status change according to income- < 10,000
Less than $10,000
After
Full Code
No Code
Before
Full Code
13(13.4%)
56(57.7%)
No Code
28(28.9%)
0
13
84
Total
McNemar's p<0.0001; OR= cannot compute with 95% C.I. ( cannot compute
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Total
69
28
97
)

Table 4.14
Code status change according to income- 10,000-29,999
$10,000-$29,999
After
Full Code
No Code
Before
Full Code
121(17.6%)
392(57.1%)
No Code
173(25.2%)
1(0.1%)
122
565
Total

Total
513
174
687

McNemar's P<0.0001; OR= 392 with 95% C.I. (55,2790)

Table 4.15
Code status change according to income- 30,000-49,999
$30,000-$49,999
After
Full Code
No Code
Before
Full Code
16(13.2%)
75(62.0%)
No Code
30(24.8%)
0
16
105
Total
McNemar's p<0.0001; OR= cannot compute with 95% C.I. (cannot compute

Total
91
30
121
)

Table 4.16
Code status change according to income- 50,000-74,999
$50,000-$74,999
After
Full Code
No Code
Before
Full Code
3(10.7%)
21(75.0%)
No Code
4(14.3%)
0
3
25
Total

Total
24
4
28

McNemar's P<0.0001; OR= cannot compute with 95% C.I. (cannot compute )

Table 4.17
Code status change according to income- >75,000
$75,000 or more
After
Full Code
No Code
Before
Full Code
87(15.3%)
281(49.5%)
No Code
199(35.0%)
1(0.2%)
88
480
Total

Total
368
200
568

McNemar's p<0.0001; OR= 281 with 95% C.I. (39,2000)

Research Question #1f- Socioeconomic Status
Is there a difference in code status change according to payer source pre and post
palliative intervention?
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Hypothesis #1f
No statistical difference will be detected by payer source relative to code status pre
and post palliative intervention?
The McNemar Test to test for symmetry in change using a p value<.0001 was
used for both underinsured and insured with only payer source as a predictor variable to
look at code status changes between the insured and the underinsured as profiled in tables
4.18 and 4.19. This showed change from full code to no code was 54.3% as compared to
a 0.1% change from no code to full code in the insured with an odds ratio for a matched
pair design of OR=631 with a 95% confidence interval (158,2526). Among the
underinsured, there was a 60.2% change from full code to no code as compared to a 0.2%
change from no code to full code with an odds ratio for a matched pair design of
OR=313 with a 95% confidence interval (44,2229) as profiled in table 4.19. The
intervention has both a statistically significant yield and a clinical impact on code status
for both the insured and the underinsured with difference detected.
Table 4.18
Code status change according to payer source- insured
Insured
After
Full Code
No Code
Before
Full Code
378(16.3%)
1262(54.3%)
No Code
681(29.3%)
2(0.1%)
380
1943
Total

Total
1640
683
2323

McNemar's P<0.0001; OR= 631 with 95% C.I. ( 158, 2526)

Table 4.19
Code status change according to payer source- underinsured
Underinsured
After
Full Code
No Code
Before
Full Code
118(22.7%)
313(60.2%)
No Code
88(16.9%)
1(0.2%)
119
401
Total
McNemar's P<0.0001; OR=313 with 95% C.I. (44, 2229)
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Total
431
89
520

Research Question #1g
Is there a difference in code status change according to disease distribution pre and
post and palliative intervention?
Hypothesis #1g
No statistical difference will be detected by disease distribution relative to code
status pre and post palliative intervention?
The McNemar Test to test for symmetry in change using a p value<.0001 for
those with and without cancer with only disease distribution as a predictor variable to
look at code status changes between those patients with cancer and those without cancer
as profiled in tables 4.20 and 4.21. This showed change from full code to no code was
57.9% as compared to a 0 change from no code to full code in females with an odds ratio
for a matched pair design where the OR could not be computed and thus the confidence
interval could not be computed. Among those patients without cancer, there was a 55.3%
change from full code to no code as compared to a 0.1% change from no code to full
code with an odds ratio for a matched pair design of OR=550 with a 95% confidence
interval (137,2201) as profiled in table 4.21.
Table 4.20
Code status change according to disease distribution: cancer
Cancer
After
Full Code
No Code
Before
Full Code
117(18.3%)
371(57.9%)
No Code
153(23.9%)
0
117
524
Total
McNemar's P<0.0001; OR= cannot compute with 95% C.I. (cannot compute)
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Total
488
153
641

Table 4.21
Code status change according to disease distribution: no cancer
Non-Cancer
After
Full Code
No Code
Before
Full Code
337(16.9%)
1100(55.3%)
No Code
550(27.7%)
2(0.1%)
339
1650
Total
McNemar's P<0.0001; OR=550 with 95% C.I. (137,2201)

Total
1437
552
1989

A model of final code status based on possible predictors was used through the
Logistic Regression Test analysis profiled in table 4.22. The model was used to predict
the Logit of having a full code status after the intervention. The initial model used the
predictor variables: prior code status, race, age, gender, education, income, and payer
source.
Table 4.22
Code status
Variable
Prior Code Status
Race
Age
Gender
Education
Income
Pay Source
Constant
Prior Code Status
(full code is
reference)
Race (black is
reference)
Age (66 and older
is reference)
Constant

Logistic Regression Model for predicting Full Code
Coefficient
Standard Error
P-value
4.072
0.714
<0.001
0.609
0.195
0.002
-0.602
0.169
<0.001
-0.098
0.152
0.520
(multiple
0.892
coefficients)
(multiple
0.048
coefficients)
-0.215
0.204
0.292
-5.559
0.822
<0.001
4.001

0.582

<0.001

0.529

0.119

0.002

-0.512

0.119

<0.001

-5.217

0.587

<0.001
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The test yielded Black, full code prior and over 66 for a Logit of full code
resulting in odds ratio of 0.301. The test yielded Black, full code, and aged 18-65 for a
Logit of full code equaling odds ratio of 0.503.
Combining the results of both yields, the odds ratio of a full code for a person
ages 18-65 to a person aged 66-plus with everything else being equal is 1.67. Younger
people are more likely to have a full code as opposed to older people. Further, Blacks
have higher odds of a full code status than Whites and those with a prior full code status
have higher odds of a final full status than those with a no code.
Research Question #2
Is there a difference in Stage IV, (comfort measures status) pre and post palliative
intervention?
Hypothesis #2
No statistical differences will be detected relative to comfort measures status pre
and post palliative intervention?
The McNemar Test to test for symmetry in matched pairs yielding a p
value<.0001 for the total patient population to look at care level changes between comfort
and aggressive measures, as profiled in table 4.23, showed change from aggressive to
comfort was 39% as compared to a 0.2% change from comfort to aggressive with an odds
ratio for a matched pair design of OR=185 with a 95% confidence interval (83,412). The
intervention has both statistical significance and has a clinical impact on care level status
as resulting comfort measures are 185 times more likely than resulting aggressive
measures.
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Table 4.23
Aggressive/Comfort measure changes- total population
After
Aggressive
Comfort only
Before
Aggressive
1605(56.5%)
1108(39.0%)
Comfort only
124(4.4%)
6(0.2%)
1611
1232
Total

Total
2713
130
2843

McNemar's p-value <0.0001; OR= 185 with 95% C.I. ( 83, 412)

Research Question #2a
Is there a difference in Stage IV, (comfort measures status) according to gender pre
and post palliative intervention?
Hypothesis #2a
No statistical differences will be detected by gender relative to comfort measures
status pre and post palliative intervention?
The McNemar Test to test for symmetry in matched pairs using a p value<.0001
for both females and males was used with only gender as a predictor variable to look at
care level changes between comfort and aggressive measures as profiled in tables 4.24
and 4.25. This showed a change in females from aggressive to comfort measures was
39.2% as compared to a 0.3% change from comfort to aggressive with an odds ratio for a
matched pair design of OR= 145 with a 95% confidence interval (54,386). Among males,
there was a 38.7% change from aggressive to comfort measure status as compared to a
0.1% change from comfort to aggressive measures with an odds ratio for a matched pair
design of OR=263 with a 95% confidence interval (66,1056). The intervention has both
statistical significance and a clinical impact on care level status for both females and
males with slight differences detected.
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Table 4.24
Aggressive/Comfort measure change based on gender- female
Female
After
Aggressive
Comfort only
Before
Aggressive
820(55.7%)
578(39.2%)
Comfort only
71(4.8%)
4(0.3%)
824
649
Total

Total
1398
75
1473

McNemar's p<0.0001; OR= 145 with 95% C.I. (54, 386)

Table 4.25
Aggressive/Comfort measures change based on gender- male
Male
After
Aggressive
Comfort only
Before
Aggressive
780(57.3%
527(38.7%)
Comfort only
53(3.9%)
2(0.1%)
782
580
Total

Total
1307
55
1362

McNemar's P<0.0001; OR= 263 with 95% C.I. (66, 1056)

Research Question #2b
Is there a difference in Stage IV, (comfort measures status) according to race pre
and post palliative intervention?
Hypothesis #2b
No statistical differences will be detected by race relative to comfort measures status
pre and post palliative intervention?
The McNemar Test to test for symmetry in matched pairs using a p value<.0001
for both race categories was used with only race as a predictor variable to look at care
level changes between comfort and aggressive measures as profiled in tables 4.26 and
4.27. This showed a change from aggressive to comfort in Blacks was 31.4% as
compared to a 0.2% change from comfort to aggressive measures with an odds ratio for a
matched pair design of OR=157 with a 95% confidence interval (39,629). Among
Whites, there was a 44.4% change from aggressive to comfort care as compared to a
0.1% change from comfort to aggressive care with an odds ratio for a matched pair
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design of OR=318 with a 95% confidence interval (79,1274). The intervention has both a
statistically significant yield and a clinical impact on care level status for both Black and
Whites, and with significant difference detected.
Table 4.26
Aggressive/Comfort measure status by race- Black
Black
After
Aggressive
Comfort only
Before
Aggressive
648(65.1%)
313(31.4%
Comfort only
33(3.3%)
2(0.2%)
650
346
Total

Total
961
35
996

McNemar's p<0.0001; OR= 157 with 95% C.I. (39, 629)

Table 4.27
Aggressive/Comfort measure status by race- White
White
After
Aggressive
Comfort only
Before
Aggressive
725(50.6%)
636(44.4%)
Comfort only
69(4.8%)
2(0.1%)
727
705
Total

Total
1361
71
1432

McNemar's P<0.0001; OR= 318 with 95% C.I. (79, 1274)

Research Question #2c
Is there a difference in Stage IV, (comfort measures status) according to age pre and
post palliative intervention?
Hypothesis #2c
No statistical differences will be detected by age relative to comfort measures status
pre and post palliative intervention?
The McNemar Test to test for symmetry in matched pairs using a p value<.0001
was used with only age as a predictor variable for both age groups to look at care level
changes between comfort and aggressive measures as profiled in tables 4.28 and 4.29.
Those aged 18-65 showed change from aggressive to comfort status was 36% as
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compared to a 0.1% change from comfort to aggressive with an odds ratio for a matched
pair design of OR=336 with a 95% confidence interval (47,2392). Among those aged
66+, there was a 41.4% change from aggressive to comfort care as compared to a 0.2%
change from comfort to aggressive care with an odds ratio for a matched pair design of
OR=185 with a 95% confidence interval (65,494). The intervention has both a
statistically significant yield and a clinical impact on care level status for both age
groups, and with significant differences detected.
Table 4.28
Aggressive/ Comfort measure status by age-18-65
18-65
After
Aggressive
Comfort only
Before
Aggressive
575(61.6%0
336(36.0%)
Comfort only
22(2.4%)
1(0.1%)
576
358
Total

Total
911
23
934

McNemar's p<0.0001; OR= 336 with 95% C.I. (47, 2392)

Table 4.29
Aggressive/Comfort measure status by age-66+
66+
After
Aggressive
Comfort only
Before
Aggressive
950(53.2%)
739(41.4%)
Comfort only
93(5.2%)
4(0.2%)
954
832
Total

Total
1689
97
1786

McNemar's P<0.0001; OR= 185 with 95% C.I. (69, 494)

Research Question #2d- socioeconomic status
Is there a difference in Stage IV, (comfort measures status) according to education
level pre and post palliative intervention?
Hypothesis #2d
No statistical differences will be detected by education level relative to comfort
measures status pre and post palliative intervention?
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The McNemar Test to test for symmetry in matched pairs using a p value<.0001
was used for all education levels with only education as a predictor variable to look at
care level changes between comfort and aggressive measures as profiled in tables 4.30,
4.31 and 4.32. For those in the less than high school category, a 31.3% change showed
from aggressive to comfort measures. There was a zero for the measure from comfort to
aggressive so no OR or confidence interval computation could be conducted. Those with
a high school diploma showed a change from aggressive to comfort at 41.8% as
compared to a 0.3% change from comfort to aggressive in with an odds ratio for a
matched pair design of OR=147 with a 95% confidence interval (47,58). Among those
patients with some college education and beyond, there was a 41% change from
aggressive to comfort measures as compared to a 0.6% change from comfort to
aggressive care with an odds ratio for a matched pair design at OR= 70 with a 95%
confidence interval (17,281).
Table 4.30
Aggressive/Comfort measure status by education level- less than high school
Less than H.S.
After
Total
Aggressive
Comfort only
Before
Aggressive
227
337
110(31.3%)
Comfort only
14(4.0%)
14
0
227
124
351
Total
McNemar's p<0.0001; OR= cannot compute with 95% C.I. (cannot compute)
Table 4.31
Aggressive/Comfort measure status by education level- high school diploma
H.S. Diploma
After
Total
Aggressive
Comfort only
Before
Aggressive
563
1004
441(41.8%)
Comfort only
47(4.5%)
50
3(0.3%)
566
488
1054
Total
McNemar's P<0.0001; OR= 147 with 95% C.I. (47,458)
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Table 4.32
Aggressive/Comfort measures status by education level- college
College
After
Aggressive
Comfort only
Before
Aggressive
179(52.8%)
139(41.0%)
Comfort only
19(5.6%)
2(0.6%)
181
158
Total

Total
318
21
339

McNemar's P<0.0001; OR= 70 with 95% C.I. (17,281)

This shows that there was some significance when comparing education levels,
while others produced no significance at all. A comparison could therefore not be made
between all three education variables.
Research Question #2e- socioeconomic status
Is there a difference in Stage IV, (comfort measures status) according to income pre
and post palliative intervention?
Hypothesis #2e
No statistical differences will be detected by income relative to comfort measures
status pre and post palliative intervention?
The McNemar Test to test for symmetry in matched pairs using a p value<.0001
for income categories and with only income as a predictor variable to look at care level
changes between comfort and aggressive measures as profiled in tables 4.33-4.37,
showed change from aggressive to comfort was 29.9% as compared to a 1.0% change
from comfort to aggressive in patients with income <$10,000 with an odds ratio for a
matched pair design of OR=29 with a 95% confidence interval (4,213). For those in the
income level ranging from $10,000-29,999, a computation could not be made. Patients
with income from the $30,000-49,999 showed change from aggressive to comfort was at
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47.1% as compared to a 0.8% change from comfort to aggressive with an odds ratio for a
matched pair design of OR=57 with a 95% confidence interval (8,425).
Those in the $50,000-74,999 income range could not be computed because of
zero value in comfort to aggressive. Lastly, those patients making >$75,000 showed a
change from aggressive to comfort was 41% as compared to a 0.2% change from comfort
to aggressive with an odds ratio for a matched pair design of OR= 223 with a 95%
confidence interval (31,1590).
Table 4.33
Aggressive/Comfort Measure Status by income <$10,000
Less than $10,000
After
Before
Aggressive
Comfort only
Aggressive
29(29.9%)
29(29.9%)
Comfort only
4(4.1%)
1(1.0%)
30
33
Total

Total
58
4
63

McNemar's p<0.0001; OR= 29 with 95% C.I. (4, 213)

Table 4.34
Aggressive/Comfort measure Status by income-10,000-29,999
$10,000-$29,999
After
Total
Aggressive
Comfort
only
Before
Aggressive
399(58.1%)
660
261(38.0%)
Comfort only
27(3.9%)
27
0
399
288
687
Total
McNemar's P<0.0001; OR= cannot compute with 95% C.I. (cannot compute )
Table 4.35
Aggressive/Comfort measure status by income- 30,000-49,999
$30,000-$49,999
After
Aggressive
Comfort only
Before
Aggressive
58(47.9%)
57(47.1%)
Comfort only
5(4.1%)
1(0.8%)
59
62
Total
McNemar's p<0.0001; OR= 57 with 95% C.I. (8,425)
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Total
115
6
121

Table 4.36
Aggressive/Comfort measure status by income- 50,000-74,999
$50,000-$74,999
After
Aggressive
Comfort only
Before
Aggressive
15(53.6%)
12(42.9%)
Comfort only
1(3.6%)
0
15
13
Total

Total
27
1

McNemar's P<0.0001; OR= cannot compute with 95% C.I. (cannot compute)

Table 4.37
Aggressive/Comfort measure status by income- >75,000
$75,000 or more
After
Aggressive
Comfort only
Before
Aggressive
306(53.9%)
223(41.0%)
Comfort only
28(4.9%)
1(0.2%)
307
251
Total

Total
529
29
558

McNemar's p<0.0001; OR= 223 with 95% C.I. (31, 1590)

Research Question #2f
Is there a difference in Stage IV, (comfort measures status) according to payer
source pre and post palliative intervention?
Hypothesis #2f
No statistical differences will be detected by payer source relative to comfort
measures status pre and post palliative intervention?
The McNemar Test to test for symmetry in matched pairs using a p value<.0001
for both insured and underinsured was used with only payer source as a predictor variable
to look at care level changes between comfort and aggressive measures as profiled in
tables 4.38 and 4.39. The insured population showed a change from aggressive to comfort
was 38.4 % as compared to a 0.1% change from comfort to aggressive with an odds ratio
for a matched pair design of OR= 298 with a 95% confidence interval (96,925). Among
the underinsured, there was a 41.3% change from aggressive to comfort measures as
compared to a 0.6% change from comfort to aggressive care with an odds ratio for a
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matched pair design of OR=72 with a 95% confidence interval (23,224). The
intervention has both a statistically significant impact and a clinical impact on code status
for both the insured and underinsured with no difference detected.
Table 4.38
Aggressive/Comfort measure status by payer source -insured
Insured
After
Aggressive
Comfort only
Before
Aggressive
1311(56.4%)
893(38.4%)
Comfort only
116(5.0%)
3(0.1%)
1314
1009
Total

Total
2204
119
2323

McNemar's P<0.0001; OR= 298 with 95% C.I. (96,925)

Table 4.39:
Aggressive/Comfort measure status by payer source- underinsured
Underinsured
After
Aggressive
Comfort only
Before
Aggressive
294(56.5)
215(41.3%)
Comfort only
8(1.5%)
3(0.6%)
297
223
Total

Total
509
11
520

McNemar's P<0.0001; OR=72 with 95% C.I (23, 224)

Research Question #2g
Is there a difference in Stage IV, (comfort measures status) according to disease
distribution pre and post palliative intervention?
Hypothesis #2g
No statistical differences will be detected by disease relative to comfort measures
status pre and post palliative intervention?
The McNemar Test to test for symmetry in matched pairs using a p value<.0001
for both categories was used with only disease as a predictor variable to look at care level
changes between comfort and aggressive measures as profiled in tables 4.40 and 4.41.
Patients with cancer showed a change from aggressive to comfort measures at 36% as
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compared to a 0.2% change from comfort to aggressive with an odds ratio for a matched
pair design of OR=231 with a 95% confidence interval (32,1647). Among those without
cancer, there was a 40.8% change from aggressive to comfort as compared to a 0.3%
change from comfort to aggressive measures with an odds ratio for a matched pair design
of OR=162 with a 95% confidence interval (67,391). The intervention has both statistical
significance and a clinical impact on code status for those patients with cancer and those
with other primary conditions with limited differences detected.
Table 4.40
Aggressive/ comfort status for disease distribution-cancer
Cancer
After
Aggressive
Comfort only
Before
Aggressive
385(60.1%)
231(36.0%)
Comfort only
24(3.7%)
1(0.2%)
386
255
Total

Total
616
25
641

McNemar's P<0.0001; OR= 231 with 95% C.I. ( 32, 1647)

Table 4.41
Aggressive/comfort status for disease distribution-no cancer
Non-Cancer
After
Aggressive
Comfort only
Before
Aggressive
1087(54.7)
812(40.8%)
Comfort only
85(4.3%)
5(0.3%)
1092
897
Total

Total

McNemar's P<0.0001; OR=162 with 95% C.I. (67, 391)

A model of final comfort status based on possible predictors using Logistic
Regression shown below in tables 4.42. The model was used to predict the Logit of
having an aggressive care status after the intervention. Using the initial model with the
predictor variables: prior comfort status, race, age, gender, education, income, and payer
source, the analysis yielded the following results: The Logit for Blacks with less than
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high school and prior aggressive care is computed to an odds of 2.42. For Whites with
less than high school and prior aggressive care the odds are 1.57. The odds ratio is 1.54.
Therefore, the odds of having a Black patient with aggressive care and less than a
high school education is 54% greater than that of a White patient with the same education
and prior aggressive care. A White patient in the same level is more than 50% more
likely to have comfort measure status. Based on multiple full model-reduced model
fittings and tests, the best final model is summarized below in table 4.42 with less than
high school as the reference.
Table 4.42
Aggressive/ Comfort measures Status- multiple variables
Logistic Regression Model for predicting Aggressive Care
Variable
Coefficient
Standard Error
P-value
3.412
0.596
<0.001
Prior care
0.488
0.139
<0.001
Race
-0.242
0.130
0.063
Age
0.130
0.111
0.240
Gender
(multiple
0.020
Education
coefficients)
(multiple
0.158
Income
coefficients)
-0.244
0.161
0.130
Pay Source
-2.587
0.663
<0.001
Constant
Prior Comfort
(Aggressive Care)
Race (black is
reference)
Education (HS
diploma)
Education
(College)
Constant

3.444
0.431

0.594
0.115

<0.001
<0.001

-0.384

0.148

0.009

-0.256

0.183

0.163

-2.991

0.606

<0.001
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Research Question 3a, 3c, 3f
Is there a difference in Hospice discharge according to (a)gender, (c)age (f)payer
source following a palliative care intervention?
Hypothesis #3a
No statistical differences will be detected relative to (a)gender, (c)age, (f)payer
source for hospice discharge following the palliative intervention?
The Likelihood Ratio Chi-Square Test was used to measure outcome differences
relative to hospice discharge. The likelihood function was first used to determine the best
model and to determine the parameters of the chi-square. Many of the demographic
variables produced no significant results relative to hospice discharge. When measuring
gender differences, as profiled in table 4.43, p=0.131 there was no significance shown.
When measuring age difference as profiled in table 4.44, p=0.757, with no significant
difference between those aged 18-65 and those aged 66-plus. When measuring pay
source profiled in table 4.45, p=0.311, with no significant differences in the insured and
underinsured with respect to hospice discharge. Thus, we fail to reject the null for these
research questions.
Table 4.43
Hospice discharge according to gender
Gender

Used Hospice
after
discharge

Female
Male
Total

243(18.7%)
247(20.8%)
490

Hospice Discharge
No Hospice
Died in
Hospital *
hospice in
hospital
269(20.7%)
785(60.5%)
212(17.9%)
727(61.3%)
481
1512

Total

1297(100.0%)
1186(100.0%)
2483

Likelihood Ratio Chi-Square = 4.065 with 2 df, p=0.131 No significant difference in hospice with respect
to gender.
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Table 4.44
Hospice discharge according to age
Age

Used Hospice
after
discharge

18-65
66 and older
Total

154(19.1%)
317(20.1%)
471

Hospice Discharge
No Hospice
Died in
Hospital *
hospice in
hospital
153(18.9%)
501(62.0%)
305(19.4%)
953(60.5%)
458
1454

Total

808(100.0%)
1575(100.0%)
2383

Likelihood Ratio Chi-Square = 0.557 with 2 df, p=0.757 No significant difference in hospice with respect
to age.

Table 4.45
Hospice discharge according to pay source
Pay Source

Used Hospice
after
discharge

Insured
Underinsured
Total

413(20.3%)
80(17.5%)
493

Hospice Discharge
No Hospice
Died in
Hospital *
hospice in
hospital
395(19.4%
1224(60.2%)
86(18.8%)
291(63.7%)
481
1515

Total

2032(100%)
457(100%)
2489

Likelihood Ratio Chi-Square = 2.337 with 2 df, p=0.311 No significant difference in hospice with respect
to Pay Source

Research Question #3b
Is there a difference in Hospice discharge according to race following a palliative
care intervention?
Hypothesis #3b
No statistical differences will be detected relative to race for hospice discharge
following the palliative intervention?
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When measuring for differences in hospice rate of discharge with respect to race,
the Likelihood Ratio Chi-Square Test yielded p<.001, which is statistically significant
indicating that Blacks are less likely than Whites to use hospice services as profiled in
table 4.46.
Table 4.46
Hospice discharge according to race
Race

Used Hospice
after
discharge

Black
White
Total

172(19.4%)
228(18.4%)
400

Hospice Discharge
No Hospice
Died in
Hospital *
hospice in
hospital
218(24.6%)
495(55.9%)
166(13.4%)
845(68.2%)
384
1340

Total

885(100.0%)
1239(100.0%)
2124

Likelihood Ratio Chi-Square = 48.140 with 2 df, p<0.001

Research Question #3d
Is there a difference in Hospice discharge according to socioeconomic statuseducation level following a palliative care intervention?
Hypothesis #3d
No statistical differences will be detected by socioeconomic status- education level
hospice discharge following the palliative intervention?
For those patients measured by education level, table 4.47 presents data to profile
the results of the Likelihood Chi-Square analysis in comparing patients and education
level. The test yielded a p=0.010. This shows that there was significant difference among
those patients with less than high school, indicating a higher likelihood for no hospice for
these patients.
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Table 4.47
Hospice discharge according to education
Education

Used Hospice
after
discharge

Less than HS
HS Diploma
College
Total

76(24.9%)
187(19.8%)
54(19.4%)
317

Hospice Discharge
No Hospice
Died in
Hospital *
hospice in
hospital
74(24.3%)
155(50.8%)
174(18.4%)
584(61.8%)
48(17.3%)
176(63.3%)
296
915

Total

305(100.0%)
945(100.0%)
278(100.0%)
1528

Likelihood Ratio Chi-Square = 13.187 with 4 df, p=0.010

Research Question #3e Is there a difference in hospice discharge according to socioeconomic status-income
following a palliative care intervention?
Hypothesis #3e
No statistical differences will be detected by socioeconomic discharge-income
relative to hospice discharge following the palliative intervention?
For the income variable comparison relative to hospice discharge, table 4.48
profiles the results of the Likelihood Ratio Chi-Square analysis.
Table 4.48
Hospice discharge according to income
Income

Used Hospice
after
discharge

Less than
10,000
10,000-29,999
30,000-49,999
50,000-74,999
75,000 or
more
Total

14(15.9%)

Hospice Discharge
No Hospice
Died in
Hospital *
hospice in
hospital
54(61.4%)
20(22.7%)

115(19.0%)
17(17.2%)
7(25.9%)
100(20.3%)

135(22.3%)
15(15.2%)
4(14.8%)
68(13.8%)

356(58.7%)
67(67.7%)
16(59.3%)
324(65.9%)

606(100%)
99(100%)
27(100%)
492(100%)

253

242

817

1312

Likelihood Ratio Chi-Square = 16.794 with 8 df, p=0.032
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Total

88(100%)

The test is comparing those with lower income levels to those with higher
incomes. The test yields a p=0.032. This shows a significant difference with respect to
income. As income goes up, the percentage for no hospice decreases.
Research Question 3g
Is there a difference in Hospice discharge according to disease following a palliative
care intervention?
Hypothesis #3g
No statistical differences will be detected relative to disease for hospice discharge
following the palliative intervention
Using the Likelihood Ratio Chi-Square as profiled in table 4.49, cancer patients
were compared to non-cancer patients. The test yielded a p<.001 showing a higher
number of cancer patients used hospice care. This indicated significance.
Table 4.49
Hospice discharge according to disease distribution
Distribution of Disease
Hospice D/C
Cancer
Not Cancer
Total
297(65.4%)
454
Used Hospice
157(34.6%)
after discharge
346(78.1%)
443(100%)
No Hospice
97(21.9%)
1091(77.7%)
1405
Died in Hospital * 314(22.3%)
hospice in hospital
568
1734
2302
Total
Likelihood Ratio Chi-Square = 29.904 with 2 df, p<0.001.

For the purpose of measuring the intervention’s impact and differences in variable
groups according to cost, length of stay and days saved were used as measurement tools.
For the length of stay analysis, the McNemar-Bowker test of symmetry was used. To
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analyze the days saved measurement of cost, both the t-test and the Anova and
Bonferroni were used as profiled in the tables below.
Research Question #4
Is there a difference in cost per length of stay pre and post palliative care
intervention?
Hypothesis #4
No statistical differences will be detected relative to cost per length of stay pre and
post palliative intervention
For the total population of patients, length of stay categories were measured using
the McNemar-Bowker test of symmetry. Table 4.50 profiles data to show significance in
the decrease of length of stay post intervention. The test yielded a p-value<0.001,
showing a lack of symmetry in the distribution of changes and significance. The
decrease overall occurs in category 7-14 days with a change from 15.5% to 10.0%, in the
category of 15-21 days the change was 3.3% to 1.2% and in >21 days a decrease from
8.6% to 1.4%.
Table 4.50
Length of stay
% is of
total
LOS
0-6 days
before
PCC
1275(49.3%)
0-6 days
7-14 days 402(15.5%)
15-21 days 85(3.3%)
> 21 days 222(8.6%)
1984(76.7%)
Total

LOS after PCC
7-14 days

15-21 days

259(10.0%)
74(2.9%)
23(0.9%)
60(2.3%)
416(16.1%)

31(1.2%)
20(0.8%)
5(0.2%)
19(0.7%)
75(2.9%)

> 21 days

36(1.4%)
29(1.1%)
8(0.3%)
39(1.5%)
112(4.3%)
McNemar-Bowker test of symmetry statistic is 205.656 with 6 df and p<0.001.
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Total

1601(61.9%)
525(20.3%)
121(4.7%)
340(13.1%)
2587(100%)

Research Question #4a, 4b, 4c, 4d, 4e, 4f, 4g
Is there a difference in cost per length of stay pre and post palliative care
intervention?
Hypothesis #4a, 4b, 4c, 4d, 4e, 4f, 4g
No statistical differences will be detected relative to cost per length of stay pre and
post palliative intervention
As stated above, length of stay could not be computed in 2-by-2 tables for each
variable analysis, or further for a multivariate analysis. Therefore, we cannot accept nor
fail to reject the null.
Research Question #5
Is there a difference in cost per days saved following a palliative care intervention?
Hypothesis #5
No statistical differences will be detected relative to cost per days saved following
palliative intervention?
The overall days saved mean=3.68 with a standard deviation=4.05 for N=2843.
The t-test analysis showed no significant differences with respect to gender, race, pay
source, education or income, indicating the null hypothesis was accepted for variables of
race and socioeconomic status, age and gender with respect to cost. However,
significance was found with variables of age profiled in table 4.51, in disease distribution
profiled in table 4.52, and in hospice discharge profiled in table 4.53 below.
Research Question #5a, 5b, 5d, 5e, 5f
Is there a difference in cost per days saved following a palliative care intervention?
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Hypothesis #5a, 5b, 5d, 5e, 5f
No statistical differences will be detected relative to cost per days saved following
palliative intervention
Again, no significance was found with respect to gender, race, education, income,
or payer source. Therefore, we fail to reject the null.
Research Question #5c
Is there a difference in cost per days saved by age following a palliative care
intervention?
Hypothesis #5c
No statistical differences will be detected by age relative to cost per days saved
following palliative intervention
Using age as a lone predictor variable for days saved, the t-test analysis yielded a
p-value=0.036 profiled in table 4.51 with a difference of .35 days between ages 18-65
and those aged 66+. This indicated significance and a clinical cost impact post
intervention. The patients aged 18-65 had a higher mean for days saved.
Table 4.51
Days saved according to age
Age
N
Mean
18-65
66 and
older

934
1786

3.93
3.58

Standard
deviation
4.73
3.65

t-statistic
(df)
2.104(2718)

p-value
0.036

There is a significant difference and it is .35 days per 18-65 year old person

Research Question #5g
Is there a difference in cost per days saved by disease following a palliative care
intervention?
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Hypothesis #5g
No statistical differences will be detected relative to cost per days saved by disease
following palliative intervention?
Using disease distribution as a lone predictor variable for days saved, the t-test
analysis yielded a p-value=.002 with a .59 difference between those with cancer and
those with no cancer, profiled in table 4.52.
This indicated significance and a clinical cost impact. The non-cancer patients had
a higher mean of days saved.
Table 4.52
Days saved according to disease distribution
Age
N
Mean
Standard
deviation
641
3.28
3.39
Cancer
3.87
4.30
Not Cancer 1989

t-statistic
(df)
-3.133(2628)

p-value
0.002

There is a significant difference and it is .59 days per non-cancer person

Research Question #5h
Is there a difference in cost per days saved by a hospice population following a
palliative care intervention?
Hypothesis #5h
No statistical differences will be detected relative to cost per days saved by hospice
population following palliative intervention?
Using only discharge to hospice as a variable for days saved the Anova and
Bonferri test yielded a p-value<0.001, which is statistically significant. Bonferri
adjustments to the cell means were made profiled in table 4.53.
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Table 4.53
Days saved according to hospice status
Hospice D/C
N
Mean
Used hospice
after discharge
No hospice
Died in
Hospital *
hospice in
hospital

493

3.69b

Standard
deviation
3.73

481
1515

2.02a
4.29c

3.26
4.09

F-statistic

p-value

58.997

<0.001

There is a statistically significant result with p<0.001. Bonferroni adjustments to the cell means were
made and the letters next to the means indicate the difference. Means with the same letters are not
different

Systematic Sample
In addition to the analysis above, a ten percent systematic sample was selected to
determine if there were cost savings in dollars as a result of the palliative intervention.
The Principal Investigator did not use the total patient population because of privacy
constraints and access stipulations placed by the Medical Center. To extract cost data in
an objective way which upheld the regulations and efficiency constraints placed by both
MCCG and the Georgia Southern University Institutional Review Board, the cost data
had to be taken directly from the record by an objective third party. A financial audit then
took place by an objective third party for each random patient chosen. The information
extracted gave the costs per day pre and post palliative intervention. A difference was
then taken from both categories and the average mean of the days before and after the
intervention along with the average mean difference was calculated as profiled in table
4.54.
To achieve the sample, a unique identifier called “patient one” was randomly
selected and from there, every tenth patient became part of this systematic sample. The
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total random sampling process resulted in approximately 10% of the total patient
population, or n=292.
The mean cost per day prior to a palliative intervention was $2,229.46. The mean
cost per day following the palliative intervention was $731.17. The mean difference in
cost per day was $1,498.29. This systematic random sample showed that $1,498.29 per
day was saved after a palliative intervention occurred.
To conduct the cost analysis, adjustments were made for twenty-six patients with
missing data, equaling 9.3% of the randomly chosen population. It should also be stated
that there was a $0.00 amount following the intervention for forty-seven of the patients
randomly chosen. This was probably a result of withdrawal of all care and subsequent
death following the intervention, or a result of immediate discharge from the hospital to a
hospice facility following the intervention. It does not skew analysis to include the $0.00
patients because the intervention was the means to the withdrawal or the discharge.
Table 4.54
Cost savings average pre and post intervention: random sample n=292
Before
After
Difference
$2229.46
$731.17
$1498.29
Summary of Results
In summary, the data showed significant findings. The McNemar test of
symmetry in code status revealed six significant findings when using lone predictor
variables to look at change in code status pre and post palliative intervention, rejecting
Hypotheses #1, #1a, #1b, #1c, #1e, and #1f outright. For Hypotheses #1d and #1g, one
category showed difference but others could not be computed resulting in the inability to
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reject or to fail to reject the null. The multivariate analysis concluded that specific
differences were found when looking at race and age. Both younger people and Blacks
were more likely to stay full code. The McNemar test of symmetry in aggressive and
comfort measures also yielded six significant findings and rejected Hypothesis #2, #2a,
#2b, #2c, #2f, and #2g. Hypothesis #2d and #2e could neither be accepted nor rejected
because of the inability to compute all categories. Specific differences were found when
looking at race and socioeconomic status in the same analysis. The multivariate analysis
for comfort and aggressive measures showed that Blacks with a less than high school
education were more likely to choose aggressive measures than Whites with the same
education level.
The Likelihood Ratio Chi-Square Test relative to hospice discharge revealed four
significant findings, rejecting Hypotheses #3b, #3d, #3e and #3g and failing to reject #3a,
#3c, and 3f. The overall findings suggest that Blacks are less likely to use hospice. Those
with lower income are more likely to choose “no hospice” and cancer patients are more
likely to use hospice. Specific differences were found when looking at race and
socioeconomic status.
The McNemar-Bowker test of symmetry to test for costs saved by length of stay
showed significant decrease in overall costs, rejecting Hypothesis #4. However, due to
the complexity of the variables, there was no known current test to compare other
predictor variables and Hypotheses #4a- #4g could neither be proven or disproven. Both
the t-test and ANOVA Bonferroni showed five significant findings comparing days saved
as a cost measure and rejected Hypotheses #5, #5c, #5e, #5g and #5h. However, no
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differences were found relative to gender, race or socioeconomic status, failing to reject
Hypothesis #5a, #5b, #5d, #5e, and #5f.
In summary of the data analysis, it appears that the palliative intervention showed
significant differences in change of treatment level choices and significant cost reduction
overall. It also appears that there are some significant differences dependent upon
variables of age, race, disease and socioeconomic status.
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CHAPTER 5
SUMMARY, DISCUSSION, AND CONCLUSIONS
The purpose of this study was to examine differences in treatment level at the end
of life according to socioeconomic status and race. The intent is to provide a better
understanding of population differences in treatment level preferences at the end of life
and further understanding of the palliative intervention.
This final chapter is organized into the sections listed below which pertain to the
relevant discussion, conclusions, and implications of this study: (1) summary of findings;
(2) conclusions; (3) discussion; (4) strengths and limitations; (5) implications for public
health; and finally (6) suggestions for future research.
Summary of Findings
This study represented a large patient population in both rural and suburban
Georgia. A sample size of N= 2,920 showed a diverse patient population by gender, age,
illness, race and socioeconomic status representing eight counties surrounding the Macon
area.
Research Question #1: Descriptive analysis of data pertaining to code status
demonstrated that the change to no code status/DNR was over 50% higher than the
change from no code to full code. Data reflected the significance of change for both
gender variables, both race categories of Black and White, in both age categories, and for
both cancer and non-cancer patients. Data further reflected this significant shift from full
code to no code in some categories of education and income in both categories of the
insured and the underinsured indicating changes in levels of socioeconomic status.
Further investigation of the code status changes presented data that suggested that
96

younger people are more likely to stay full code than DNR when everything else is equal.
Multivariate analysis also demonstrated that Blacks have higher odds of full code status
than Whites. It was somewhat surprising that when socioeconomic status was factored
into the multivariate analysis, it did not seem to affect the outcome with any significance.
Research Question #2: Descriptive analysis of data pertaining to comfort and
aggressive measures showed close to a 40% higher rate of change from aggressive to
comfort measures only, than from comfort to aggressive measures following the
intervention for the total population. This is a surprisingly high change from aggressive to
comfort because comfort measures was defined as no treatment, only pain measures and
did not include those who shifted from for example Status I to Status III defined above.
Only Status IV patients were measured as comfort. Therefore, de-escalation may have
been present but not included in the data set. The measurement was used to represent
those who decided to remove all therapeutic curative measures.
Significant results consistent with this total population outcome were seen in
variables of gender, both female and male, in both categories of race and age, and in both
cancer and non-cancer patients. Not all categories of education and income could be
computed, but for those that could, significant changes consistent with this same outcome
were found. With respect to socioeconomic status, the payer source variable measure
showed change from aggressive to comfort measures at almost 40% for both the insured
and underinsured.
Further investigation of the interaction between socioeconomic status and race in
change of care levels using a multivariate analysis concluded that Blacks with an
education level less than high school had 54% higher chance likelihood of using
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aggressive measures at the end of life than Whites with the same education level when all
else was equal and patients were receiving aggressive care prior to the intervention. This
is consistent with the literature cited in this study.
Research Question #3: In an examination of the factors as they may relate to a
hospice discharge, there were significant differences in hospice use based on race and
socioeconomic status. Overall, Whites were over 10% more likely to use hospice services
than Blacks. Those with lower income were less likely to use hospice services. There was
a greater than 10% difference in “no hospice” results from the lowest income category to
those making the highest income. Surprisingly, there was no significant difference in use
of hospice according to payer source. Those patients with an education level less than
high school had a higher percentage of “no hospice” than those with more education. Not
surprisingly, a higher number of cancer patients used hospice than those without cancer, a
close to 30% difference. The original use for hospice services was for cancer patients
alone, so this may support a historical trend (Stevenson & Bramson, 2009).
Research Question #4: In examining cost per length of stay, a multivariate
analysis was not included. However, for total population there was an overall decrease in
length of stay following a palliative intervention. The highest percentage decrease was in
those patients with >21 days, who showed over 5% decrease in length of stay.
Research Question #5: In examining cost per days saved, the overall mean
average days saved was 3.68 per patient following the palliative intervention. There was
a significant difference in days saved within variables of age, disease and use of hospice
discharge. Those who utilized hospice after discharge or in the hospital saved 1-2 days of
acute hospital care at the end of life.
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To summarize the findings, the palliative intervention proved to align with the
literature in respect to racial differences in choices of care. Blacks used aggressive, nonhospice care more of the time than Whites. When looking at the interaction between race
and socioeconomic status, the most significant difference is seen in Blacks and Whites
with less than high school education where Blacks choose aggressive measures over 50%
of the time more often. Further, this study’s findings showed that variables including
disease, age and socioeconomic status may factor into end of life decision making, but all
are impacted by the palliative intervention.
Conclusions
From this study, the following conclusions are made:
•

Palliative care does make an overall impact on the use of full code status and
aggressive care measures. The intervention does result in the de-escalation of care
for a significant number of patients (Research Questions #1,2).

•

America is very evidently, a society rooted in autonomy, and that applies to
healthcare at end of life in the surveyed region. Income, race, and education did not
deny the patient the ability to make an individual and diverse choice about what
treatments they would choose though these variables likely shaped that decision
(Research Questions #1,2,3).

•

This study adds to the literature on the positive effects of a palliative care program
in a hospital (Research Questions #1,2,4,5).
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•

Despite increasing use of aggressive hospital technology at the end of life,
withholding and withdrawing care are also increasingly common (Research
Question #2).

•

Though Georgia has a grade “D” rank on their palliative programs (Goldsmith,
Dietrich, Qingling, Morrison, 2008), the Medical Center of Central Georgia has a
program achieving significant results. (Research Questions #1, 2,3,4,5)

•

Blacks utilize aggressive non-hospice care more of the time than Whites (Research
Questions #2,3).

•

Specific to the interaction between socioeconomic status and race with regard to
change in care levels, Blacks with less than high school education have a greater
than 50% chance of aggressive care than Whites with the same SES.

•

Socioeconomic status appears to impact the use of hospice (Research Question #3).

•

Cancer patients appear to utilize hospice more of the time than non-cancer patients
(Research Question #3).

•

This study adds to the literature on healthcare cost reductions, showing that
palliative care interventions do result in resource savings through the decreased
length of stay, costs per day and days saved measurement tools (Research
Questions #4,5).

•

Even after all information is given to a patient and family through the conference
and clinical intervention, some may still favor a death on artificial support as their
autonomous choice representing their values for quality of end of life (Research
Questions #s 1,2,3).
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Discussion of Findings
Researchers have argued that heightened technology has become so effective at
extending life that it has become more difficult to recognize what defines end of life
(Reynolds et al., 2005). Some researchers argue this is attributable to our U.S. culture,
while others postulate that effective advancements in medical technology inhibit the
ability to grasp prognosis (Glass, 2008; Reynolds, Cooper, & McKneally, 2005). A
person’s end of life may be wrought with tests, treatments, hospitalizations, resuscitations
and artificial support, or it may be without all medical means including Cardio
Pulmonary Resuscitation and removed from the hospital realm entirely. This remains true
with this research population. Each patient experienced a unique end of life, dependent
upon many factors.
End-of-life care practices are shaped by a person’s heritage, surroundings,
religion and family. They are culturally centered. (University of Washington Medical
Center, 2007). The significant differences revealed in this study show that treatment level
decisions at end of life are unique to the patient and may change based upon the palliative
intervention, family conference and dynamics addressed by healthcare professionals.
Dying patients value symptom management and good relationships with their
physicians. Communication between patient and doctor about prognosis and goals of
care directly impact the quality of a patient’s end-of-life experience (Biola, Sloane,
Williams, Daalman, Williams, Zimmerman, 2007). The findings in this study show that
patients may be impacted to de-escalate their care when a lengthy conference and
attention to symptom and pain management is shown through the palliative intervention.
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The findings in this study align with the body of literature with respect to racial
inconsistencies with end-of-life care. This study attempted to confirm or disprove those
documented differences following this unique intervention, and ultimately showed that a
palliative intervention is beneficial in both race categories but the differential in Blacks
favoring more aggressive care, remains.
Findings consistent with variables within the realm of socioeconomic status
demonstrate the potential weaknesses of a patient centered approach in hospital care.
Socioeconomic information is not a part of the medical record. Only address and payer
source offers some glimpse at socioeconomic background. Without income and education
information, it may become difficult for healthcare professionals to address barriers of a
socioeconomic nature. For example, literacy issues and poverty can only be assumed, not
known.
Findings specific to hospice care demonstrate the continued resistance towards
hospice dependent on race, disease, education and income. Consistent with the literature,
the underutilization of hospice by all groups is documented. Though this quantitative
research does not suggest why the underuse, predictor variables do give some
examination of characteristics which may impact the decision.
Healthcare is expensive. Several studies document the cost savings and decrease
in lengths of stay which result from palliative care in the hospital (Bendaly, Groves,
Juliar, Gramelspacher, 2008). This study adds to that body of literature and findings
suggest that hospital costs are saved through lower length of stay after the intervention
has taken place. This study’s cost findings show the profound impact on days saved and
lowered length of stay without dependence on any one variable. Overall, length of stay
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was decreased dramatically. The systematic sample demonstrates more dollar specifics
on the savings as a direct result of the intervention.
Study Strengths and Limitations
This study provides researchers, and hospital leadership, practitioners and staff
with a pre and post examination of the palliative intervention and its impact on code
status, care levels, hospice use, and cost. The major strength of the study is the large
sample of patients N=2,920 examined over the three year period. It is reasonable to
conclude that results provide a true representation of patient population. The high number
of patients provides a valuable snapshot of diversity in age, race, geographic residence,
education level, income and disease. As the medical realm is ever-changing, looking at a
three year time period helped to show consistency of services within the intervention.
A second strength of this study is the focus on palliative care conducted in
Georgia. This focus not only adds to the literature where it is lacking but also
demonstrates the positive impact of a high-volume program in a Georgia hospital serving
both rural and urban patients. It is also reasonable to make the claim that the study argues
against the low rank on palliative care in this region.
Seen as a third strength, this study highlights an understated public health concern
that is the end of life. This includes end-of-life care, disparities and inconsistencies
between races and amongst socioeconomic status in end-of-life treatment choices,
enhanced quality of life at the end and high end-of-life costs. More specifically, it is
reasonable to conclude that the ability to have a meaningful discussion at end of life and
to address symptom management offered through the palliative intervention, impacts care
level choices and healthcare resources.
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As a fourth and final strength of this study, the focus on both racial and
socioeconomic variables at the end of life demonstrated the complexity of these
decisions, reasonably concluding that one variable alone may not predict an outcome.
There are limited white papers on the racial differences, while published data on
socioeconomic status impacts are lacking. Therefore, this study expanded the literature
specific to variables of geographic measurements, income, education level and race to
predict treatment choices.
As with any study, this research was not without limitations. A major limitation of
this study was the sole use of data from MCCG, including the medical record and a
subsequent footprints data source to define variables. Both the medical record data and
footprints data are entered by staff at MCCG. It is possible that measurement bias may
have affected some of the data through basic human error. Further, socioeconomic status
variables of income and education were not available through the medical record, and
therefore geocoding had to be used.
The geocoding process to define socioeconomic variables created a possible
limitation. The study was limited to using only addresses that would match a census tract.
This excluded patients without a correct street address and those with nursing home or
outlying facility addresses. Further, when population based data is gathered by the
government, to protect confidentiality, household information is not representative of that
one person, but rather the majority in the tract. Individual income and education level
cannot be accessed as public information. The census bureau provides averages for the
given area and the individual patient information must be inferred. This provides a
margin of error and a possible limitation.
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Implications for Public Health
This study provides insight into three major areas of public health- enhanced
quality of life, racial and socioeconomic disparities, and resource savings in healthcare.
Quality of life or quality of death, for the purpose of this study is an area that remains
difficult to define. The right-to-die movements highlighted concepts of dignity at the end
of life, prolonged deaths and the individual costs associated with life-sustaining
technologies (Knaus et al., 1995). What can be concluded from this study specific to the
quality of death measurement is that a patient’s care level choices are personal. For some
patients, death on artificial support is the appropriate choice while for others a death
without aggressive treatments is one that defines quality.
Few studies address racial disparities specific to the end of life (Muni et al.,
2011). Likewise, even fewer studies address socioeconomic status as a confounder to
racial differences in care choice (Muni et al., 2011). The current research addressed both
areas of disparity in public health. This study’s conclusions show increased use of
resources by minorities and those with a lower socioeconomic status, which is
inconsistent with most disparity research on primary and secondary interventions. This
finding is significant to the potential development of any public health education that
might be implemented on end-of-life care. Access to life-sustaining interventions at the
end of life is not shown to be an issue, but rather possible uninformed decisions for
potential over-use of the interventions.
The economics of death, including high healthcare costs at the end of life, are well
documented (Zhang et al., 2009). Historical trends for end-of-life spending document the
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particularly high costs associated with care in the last year of life (Emanuel & Emanuel,
1994; Luce & Rubenfield, 2002). Perhaps the most significant contribution of this study
is the evidence of cost savings through the use of a palliative program, aimed at providing
better clinical symptom management and heightened communication services for
terminal patients. In a healthcare reform era, the examination of an area which proved to
reduce healthcare costs has great implications on public health.
Finally, and more specific to public health in Georgia, is the evidence of a
regional facility’s impact on a nationally under-ranked area of medicine. In a recent
survey of hospital based palliative programs, Georgia is ranked on the lower end of
average, with 20% to 40% of hospitals recorded as having programs (Goldsmith et al.,
2008). While many hospitals in Georgia may continue to operate without a program, it
is noteworthy to highlight the success of this program and its impact on Georgia patients
in both rural and urban areas.
Suggestions for Future Research
The palliative intervention is clearly both a quantitative and a qualitative effort.
This study only used the quantitative data from pre and post interventions As a follow-up,
a qualitative study looking more closely at the intervention, and focused on geared
interdisciplinary efforts and communication, might be worthy of pursuit. The qualitative
analysis might include interviews with the counselors who conduct the family conference
and practitioners who provide assessment and clinical orders for symptom management.
This would add to the content and understanding of this study’s purpose.
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A worthy area of focus might also include utilization of active patient subjects for
qualitative review of the intervention and for a closer relationship with data. This would
also allow the researcher to define socioeconomic status based on the patient’s selfevaluation and to glean some more in-depth understanding surrounding why treatment
decisions are made. Further areas of focus might include, a more specific analysis of
status changes from I to II and II to III to define specific de-escalation of care, a more indepth categorization of primary disease condition to improve understanding of the
complexities of the patient’s illness, and an expansion of race categories to include other
minority patients like Hispanic and Asian. Further, a worthy study may focus on other
hospitals in the area to help and expand understanding of the palliative intervention and
its regional impact.
Finally, palliative care is a young area, and further investigation is needed to
better this study, and future studies are recommended.
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